Predicted Drug-Target interactions for ic dataset

Top-10 predictions for each drug

Apply filters

Hide drugs with no validated DTIs
Hide drugs with no validated prediction in top-10
Filter drugs: TBD Filter targets: TBD

In total 412 out of top-10 predicted DTIs per drug were validated.
In total, 1367 validated new DTIs are known for ic dataset, however please note that at most 698 DTIs could be predicted (i.e., some drugs have more than 10 validated DTIs).

D00035 : Proline (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00035 ( Proline )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6530 ( solute carrier family 6 member 2 ) 0.988934 0 0 0 0
2 hsa6532 ( solute carrier family 6 member 4 ) 0.9847 0 0 0 0
3 hsa6531 ( solute carrier family 6 member 3 ) 0.971736 0 0 0 0
4 hsa6529 ( solute carrier family 6 member 1 ) 0.878262 0 0 0 0
5 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.783687 0 0 0 0
6 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.721977 0 0 0 0
7 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.717633 0 0 0 0
8 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.70735 0 0 0 0
9 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.68618 0 0 0 0
10 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.684985 0 0 0 0

D00110 : Cocaine (Found 6 out of 7 validated targets)

Top-10 predicted interaction for: D00110 ( Cocaine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa11254 ( solute carrier family 6 member 14 ) 0.889649 0 0 0 0
2 hsa6534 ( solute carrier family 6 member 7 ) 0.857479 0 0 0 0
3 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.851284 1 1 0 0
4 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.826327 1 1 0 0
5 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.809486 1 1 0 0
6 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.78321 1 1 0 0
7 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.771827 1 1 0 0
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.73585 0 0 0 0
9 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.735154 1 1 0 0
10 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.702965 0 0 0 0

D00136 : Haloperidol (Found 0 out of 10 validated targets)

Top-10 predicted interaction for: D00136 ( Haloperidol )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.929124 0 0 0 0
2 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.859885 0 0 0 0
3 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.826739 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.767087 0 0 0 0
5 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.762838 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.75893 0 0 0 0
7 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.747503 0 0 0 0
8 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.729317 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.722766 0 0 0 0
10 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.708484 0 0 0 0

D00195 : Codeine (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00195 ( Codeine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.966487 0 0 0 0
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.885858 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.869743 0 0 0 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.781038 0 0 0 0
5 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.774668 0 0 0 0
6 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.772475 0 0 0 0
7 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.709062 0 0 0 0
8 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.706774 0 0 0 0
9 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.698164 0 0 0 0
10 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.689004 0 0 0 0

D00219 : Acetohexamide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00219 ( Acetohexamide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.954905 0 0 0 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.92004 1 1 0 0
3 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.792878 0 0 0 0
4 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.743613 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.733117 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.720722 0 0 0 0
7 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.679285 0 0 0 0
8 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.660687 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.657479 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.651395 0 0 0 0

D00225 : Alprazolam (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00225 ( Alprazolam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2741 ( glycine receptor alpha 1 ) 0.882316 0 0 0 0
2 hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) 0.880492 0 0 0 0
3 hsa2743 ( glycine receptor beta ) 0.836485 0 0 0 0
4 hsa2742 ( glycine receptor alpha 2 ) 0.822204 0 0 0 0
5 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.72784 0 0 0 0
6 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.718624 0 0 0 0
7 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.7054 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.70079 0 0 0 0
9 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.69807 0 0 0 0
10 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.67905 0 0 0 0

D00227 : Aminophylline (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00227 ( Aminophylline )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.814937 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.788279 0 0 0 0
3 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.784905 0 0 0 0
4 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.778113 0 0 0 0
5 hsa5026 ( purinergic receptor P2X 5 ) 0.75007 0 0 0 0
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.704545 0 0 0 0
7 hsa5024 ( purinergic receptor P2X 3 ) 0.698193 0 0 0 0
8 hsa5027 ( purinergic receptor P2X 7 ) 0.695079 0 0 0 0
9 hsa5025 ( purinergic receptor P2X 4 ) 0.693106 0 0 0 0
10 hsa9127 ( purinergic receptor P2X 6 ) 0.686188 0 0 0 0

D00228 : Amoxapine (Found 2 out of 16 validated targets)

Top-10 predicted interaction for: D00228 ( Amoxapine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6531 ( solute carrier family 6 member 3 ) 0.947958 1 0 1 0
2 hsa11254 ( solute carrier family 6 member 14 ) 0.85083 0 0 0 0
3 hsa6534 ( solute carrier family 6 member 7 ) 0.828202 0 0 0 0
4 hsa6529 ( solute carrier family 6 member 1 ) 0.800311 0 0 0 0
5 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.784005 1 0 1 0
6 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.766937 0 0 0 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.736283 0 0 0 0
8 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.730352 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.709469 0 0 0 0
10 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.691462 0 0 0 0

D00234 : Astemizole (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00234 ( Astemizole )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) 0.822765 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.775281 0 0 0 0
3 hsa3776 ( potassium two pore domain channel subfamily K member 2 ) 0.740724 0 0 0 0
4 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.73115 0 0 0 0
5 hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) 0.719094 0 0 0 0
6 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.717689 0 0 0 0
7 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.713586 0 0 0 0
8 hsa9424 ( potassium two pore domain channel subfamily K member 6 ) 0.712692 0 0 0 0
9 hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) 0.710219 0 0 0 0
10 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.707433 0 0 0 0

D00252 : Carbamazepine (Found 4 out of 4 validated targets)

Top-10 predicted interaction for: D00252 ( Carbamazepine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.890235 1 1 0 0
2 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.832212 1 1 0 0
3 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.831545 1 1 0 0
4 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.806706 1 1 0 0
5 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.78525 0 0 0 0
6 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.741712 0 0 0 0
7 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.731286 0 0 0 0
8 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.700484 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.668822 0 0 0 0
10 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.652037 0 0 0 0

D00274 : Cisapride (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00274 ( Cisapride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) 0.820102 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.771093 0 0 0 0
3 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.768458 0 0 0 0
4 hsa3776 ( potassium two pore domain channel subfamily K member 2 ) 0.75269 0 0 0 0
5 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.73489 0 0 0 0
6 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.719874 0 0 0 0
7 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.708509 0 0 0 0
8 hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) 0.705674 0 0 0 0
9 hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) 0.702087 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.697842 0 0 0 0

D00283 : Clozapine (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00283 ( Clozapine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa170572 ( 5-hydroxytryptamine receptor 3C ) 0.927938 0 0 0 0
2 hsa200909 ( 5-hydroxytryptamine receptor 3D ) 0.92472 0 0 0 0
3 hsa6530 ( solute carrier family 6 member 2 ) 0.807926 0 0 0 0
4 hsa6532 ( solute carrier family 6 member 4 ) 0.788612 0 0 0 0
5 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.757935 0 0 0 0
6 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.746146 0 0 0 0
7 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.714398 0 0 0 0
8 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.708379 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.686013 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.676444 0 0 0 0

D00293 : Diazepam (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00293 ( Diazepam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.774291 0 0 0 0
2 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.76732 0 0 0 0
3 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.767191 0 0 0 0
4 hsa6530 ( solute carrier family 6 member 2 ) 0.718798 0 0 0 0
5 hsa8001 ( glycine receptor alpha 3 ) 0.688431 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.664963 0 0 0 0
7 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.657369 0 0 0 0
8 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.633673 0 0 0 0
9 hsa6532 ( solute carrier family 6 member 4 ) 0.618098 0 0 0 0
10 hsa6531 ( solute carrier family 6 member 3 ) 0.609575 0 0 0 0

D00294 : Diazoxide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00294 ( Diazoxide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.888961 1 1 1 0
2 hsa3776 ( potassium two pore domain channel subfamily K member 2 ) 0.56603 0 0 0 0
3 hsa6530 ( solute carrier family 6 member 2 ) 0.54134 0 0 0 0
4 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.475583 0 0 0 0
5 hsa6532 ( solute carrier family 6 member 4 ) 0.464428 0 0 0 0
6 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.450156 0 0 0 0
7 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.415235 0 0 0 0
8 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.407425 0 0 0 0
9 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.406611 0 0 0 0
10 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.393881 0 0 0 0

D00303 : Disopyramide (Found 4 out of 6 validated targets)

Top-10 predicted interaction for: D00303 ( Disopyramide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.907398 1 1 0 0
2 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.848813 1 1 0 0
3 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.846872 1 1 0 0
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.846741 0 0 0 0
5 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.823107 1 1 0 0
6 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.803963 0 0 0 0
7 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.770367 0 0 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.741661 0 0 0 0
9 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.687665 0 0 0 0
10 hsa40 ( acid sensing ion channel subunit 2 ) 0.664345 0 0 0 0

D00319 : Felodipine (Found 8 out of 23 validated targets)

Top-10 predicted interaction for: D00319 ( Felodipine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.955601 1 0 0 1
2 hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) 0.945709 0 0 0 0
3 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.941673 1 0 1 1
4 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.935418 1 0 0 1
5 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.926946 1 0 1 1
6 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.9139 1 0 1 1
7 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.908973 1 0 0 1
8 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.903636 1 0 0 1
9 hsa774 ( calcium voltage-gated channel subunit alpha1 B ) 0.894641 1 0 0 1
10 hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) 0.88802 0 0 0 0

D00326 : Fluoxetine (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00326 ( Fluoxetine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.865679 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.789185 0 0 0 0
3 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.7683 0 0 0 0
4 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.730474 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.722721 0 0 0 0
6 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.709451 0 0 0 0
7 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.702797 0 0 0 0
8 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.677351 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.676504 0 0 0 0
10 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.655586 0 0 0 0

D00329 : Flurazepam (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00329 ( Flurazepam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) 0.874923 1 0 1 0
2 hsa2741 ( glycine receptor alpha 1 ) 0.868117 0 0 0 0
3 hsa2743 ( glycine receptor beta ) 0.831462 0 0 0 0
4 hsa2742 ( glycine receptor alpha 2 ) 0.81198 0 0 0 0
5 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.734566 0 0 0 0
6 hsa6530 ( solute carrier family 6 member 2 ) 0.714827 0 0 0 0
7 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.701018 0 0 0 0
8 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.699619 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.681393 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.677675 0 0 0 0

D00331 : Furosemide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00331 ( Furosemide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.876366 0 0 0 0
2 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.873876 0 0 0 0
3 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.873736 0 0 0 0
4 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.851068 0 0 0 0
5 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.826655 0 0 0 0
6 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.825009 0 0 0 0
7 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.824308 0 0 0 0
8 hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) 0.822804 0 0 0 0
9 hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) 0.8175 0 0 0 0
10 hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) 0.808804 0 0 0 0

D00332 : Gabapentin (Found 0 out of 21 validated targets)

Top-10 predicted interaction for: D00332 ( Gabapentin )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.743221 0 0 0 0
2 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.590677 0 0 0 0
3 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.587723 0 0 0 0
4 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.584871 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.560957 0 0 0 0
6 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.546541 0 0 0 0
7 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.497239 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.495639 0 0 0 0
9 hsa40 ( acid sensing ion channel subunit 2 ) 0.48604 0 0 0 0
10 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.452014 0 0 0 0

D00335 : Glipizide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00335 ( Glipizide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.913888 1 1 1 1
2 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.774638 0 0 0 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.765187 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.734329 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.728062 0 0 0 0
6 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.678479 0 0 0 0
7 hsa6530 ( solute carrier family 6 member 2 ) 0.642506 0 0 0 0
8 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.63438 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.633354 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.62927 0 0 0 0

D00336 : Glyburide (Found 1 out of 4 validated targets)

Top-10 predicted interaction for: D00336 ( Glyburide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.924312 1 1 1 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.851648 0 0 0 0
3 hsa6261 ( ryanodine receptor 1 ) 0.78524 0 0 0 0
4 hsa6263 ( ryanodine receptor 3 ) 0.768128 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.753254 0 0 0 0
6 hsa6262 ( ryanodine receptor 2 ) 0.751355 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.74191 0 0 0 0
8 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.689231 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.664543 0 0 0 0
10 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.655357 0 0 0 0

D00338 : Halazepam (Found 10 out of 15 validated targets)

Top-10 predicted interaction for: D00338 ( Halazepam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.958636 1 0 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.955534 1 0 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.955476 1 0 1 0
4 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.95384 1 0 1 0
5 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.953358 1 0 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.892353 1 0 1 0
7 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.888597 1 0 1 0
8 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.888078 1 0 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.878844 1 0 1 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.878776 1 0 1 0

D00340 : Hydrochlorothiazide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00340 ( Hydrochlorothiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.86595 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.759429 0 0 0 0
3 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.757191 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.743833 0 0 0 0
5 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.702124 0 0 0 0
6 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.696036 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.68729 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.683674 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.659531 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.638495 0 0 0 0

D00345 : Indapamide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00345 ( Indapamide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.773364 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.764982 0 0 0 0
3 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.747805 0 0 0 0
4 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.745761 0 0 0 0
5 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.738893 0 0 0 0
6 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.714169 0 0 0 0
7 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.711882 0 0 0 0
8 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.711098 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.701478 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.692791 0 0 0 0

D00349 : Isradipine (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00349 ( Isradipine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.971273 0 0 0 0
2 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.944426 0 0 0 0
3 hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) 0.934002 0 0 0 0
4 hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) 0.929054 0 0 0 0
5 hsa9254 ( calcium voltage-gated channel auxiliary subunit alpha2delta 2 ) 0.916037 1 0 1 0
6 hsa59284 ( calcium voltage-gated channel auxiliary subunit gamma 7 ) 0.908471 0 0 0 0
7 hsa27092 ( calcium voltage-gated channel auxiliary subunit gamma 4 ) 0.908189 0 0 0 0
8 hsa774 ( calcium voltage-gated channel subunit alpha1 B ) 0.904624 0 0 0 0
9 hsa784 ( calcium voltage-gated channel auxiliary subunit beta 3 ) 0.894488 0 0 0 0
10 hsa3708 ( inositol 1,4,5-trisphosphate receptor type 1 ) 0.887863 0 0 0 0

D00351 : Ketoconazole (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00351 ( Ketoconazole )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.9056 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.892684 0 0 0 0
3 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.859229 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.824566 0 0 0 0
5 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.803749 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.800371 0 0 0 0
7 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.78114 0 0 0 0
8 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.768721 0 0 0 0
9 hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) 0.760442 0 0 0 0
10 hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) 0.748767 0 0 0 0

D00354 : Lamotrigine (Found 5 out of 37 validated targets)

Top-10 predicted interaction for: D00354 ( Lamotrigine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.976322 1 0 0 1
2 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.93476 0 0 0 0
3 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.825511 1 0 0 1
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.766604 1 0 0 1
5 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.74731 0 0 0 0
6 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.69046 0 0 0 0
7 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.681164 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.67221 0 0 0 0
9 hsa9311 ( acid sensing ion channel subunit 3 ) 0.662876 1 0 0 1
10 hsa55515 ( acid sensing ion channel subunit family member 4 ) 0.65659 1 0 0 1

D00358 : Lidocaine (Found 1 out of 9 validated targets)

Top-10 predicted interaction for: D00358 ( Lidocaine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.797697 1 0 0 1
2 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.796453 0 0 0 0
3 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.726833 0 0 0 0
4 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.712517 0 0 0 0
5 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.703739 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.664474 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.620918 0 0 0 0
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.611827 0 0 0 0
9 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.592274 0 0 0 0
10 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.589316 0 0 0 0

D00364 : Loratadine (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00364 ( Loratadine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.891457 0 0 0 0
2 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.880795 0 0 0 0
3 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.870976 0 0 0 0
4 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.865171 0 0 0 0
5 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.862275 0 0 0 0
6 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.853827 0 0 0 0
7 hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) 0.850728 0 0 0 0
8 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.845168 0 0 0 0
9 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.839836 0 0 0 0
10 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.830108 0 0 0 0

D00367 : Mazindol (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00367 ( Mazindol )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.975173 1 1 1 0
2 hsa11254 ( solute carrier family 6 member 14 ) 0.871271 0 0 0 0
3 hsa6534 ( solute carrier family 6 member 7 ) 0.849153 0 0 0 0
4 hsa6529 ( solute carrier family 6 member 1 ) 0.83443 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.784722 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.766521 0 0 0 0
7 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.720052 0 0 0 0
8 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.687313 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.679512 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.677999 0 0 0 0

D00373 : Thioridazine (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00373 ( Thioridazine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.914161 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.901469 0 0 0 0
3 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.852416 0 0 0 0
4 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.850263 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.811981 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.802151 0 0 0 0
7 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.783863 0 0 0 0
8 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.759238 0 0 0 0
9 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.742332 0 0 0 0
10 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.734055 0 0 0 0

D00379 : Tolazamide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00379 ( Tolazamide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.90547 1 1 0 0
2 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.772668 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.745691 0 0 0 0
4 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.744007 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.739349 0 0 0 0
6 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.696152 0 0 0 0
7 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.650093 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.643702 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.631673 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.628906 0 0 0 0

D00380 : Tolbutamide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00380 ( Tolbutamide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.945084 1 1 0 0
2 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.847454 0 0 0 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.718141 0 0 0 0
4 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.714966 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.691887 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.675768 0 0 0 0
7 hsa6530 ( solute carrier family 6 member 2 ) 0.660411 0 0 0 0
8 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.643411 0 0 0 0
9 hsa6532 ( solute carrier family 6 member 4 ) 0.628888 0 0 0 0
10 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.628742 0 0 0 0

D00392 : Trimethadione (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00392 ( Trimethadione )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.97175 0 0 0 0
2 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.963862 0 0 0 0
3 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.784597 0 0 0 0
4 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.782328 0 0 0 0
5 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.771807 0 0 0 0
6 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.753246 0 0 0 0
7 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.745733 0 0 0 0
8 hsa6261 ( ryanodine receptor 1 ) 0.737077 0 0 0 0
9 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.719115 0 0 0 0
10 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.717416 0 0 0 0

D00394 : Trimipramine (Found 2 out of 2 validated targets)

Top-10 predicted interaction for: D00394 ( Trimipramine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6531 ( solute carrier family 6 member 3 ) 0.934614 1 0 1 0
2 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.90326 0 0 0 0
3 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.83417 0 0 0 0
4 hsa11254 ( solute carrier family 6 member 14 ) 0.830485 0 0 0 0
5 hsa6534 ( solute carrier family 6 member 7 ) 0.807744 0 0 0 0
6 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.796939 0 0 0 0
7 hsa6529 ( solute carrier family 6 member 1 ) 0.781356 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.745085 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.7197 1 0 1 0
10 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.718191 0 0 0 0

D00418 : Minoxidil (Found 6 out of 72 validated targets)

Top-10 predicted interaction for: D00418 ( Minoxidil )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.916301 1 1 0 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.897581 1 1 0 0
3 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.762545 0 0 0 0
4 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.747868 0 0 0 0
5 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.732104 1 0 0 1
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.724671 1 0 0 1
7 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.714934 1 0 0 1
8 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.682783 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.675518 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.664221 1 0 0 1

D00437 : Nifedipine (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00437 ( Nifedipine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.695623 0 0 0 0
2 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.670617 0 0 0 0
3 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.645725 0 0 0 0
4 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.58009 0 0 0 0
5 hsa56659 ( potassium two pore domain channel subfamily K member 13 ) 0.560955 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.552418 0 0 0 0
7 hsa6530 ( solute carrier family 6 member 2 ) 0.552147 0 0 0 0
8 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.534166 0 0 0 0
9 hsa6340 ( sodium channel epithelial 1 gamma subunit ) 0.515923 0 0 0 0
10 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.512871 0 0 0 0

D00438 : Nimodipine (Found 2 out of 4 validated targets)

Top-10 predicted interaction for: D00438 ( Nimodipine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.987873 1 1 1 0
2 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.976376 0 0 0 0
3 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.963362 0 0 0 0
4 hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) 0.932148 1 0 1 0
5 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.93045 0 0 0 0
6 hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) 0.927176 0 0 0 0
7 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.915094 0 0 0 0
8 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.912943 0 0 0 0
9 hsa9254 ( calcium voltage-gated channel auxiliary subunit alpha2delta 2 ) 0.911115 0 0 0 0
10 hsa774 ( calcium voltage-gated channel subunit alpha1 B ) 0.908606 0 0 0 0

D00451 : Sumatriptan (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00451 ( Sumatriptan )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa170572 ( 5-hydroxytryptamine receptor 3C ) 0.938787 0 0 0 0
2 hsa200909 ( 5-hydroxytryptamine receptor 3D ) 0.936725 0 0 0 0
3 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.786975 0 0 0 0
4 hsa6530 ( solute carrier family 6 member 2 ) 0.761222 0 0 0 0
5 hsa6532 ( solute carrier family 6 member 4 ) 0.750611 0 0 0 0
6 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.742047 0 0 0 0
7 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.728947 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.693103 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.657727 0 0 0 0
10 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.655975 0 0 0 0

D00456 : Ondansetron (Found 4 out of 4 validated targets)

Top-10 predicted interaction for: D00456 ( Ondansetron )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.965364 1 1 0 0
2 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.956755 1 1 0 0
3 hsa170572 ( 5-hydroxytryptamine receptor 3C ) 0.912565 1 1 0 0
4 hsa200909 ( 5-hydroxytryptamine receptor 3D ) 0.90872 1 1 0 0
5 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.807317 0 0 0 0
6 hsa6530 ( solute carrier family 6 member 2 ) 0.790162 0 0 0 0
7 hsa6532 ( solute carrier family 6 member 4 ) 0.771855 0 0 0 0
8 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.769606 0 0 0 0
9 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.747065 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.727158 0 0 0 0

D00464 : Oxazepam (Found 10 out of 15 validated targets)

Top-10 predicted interaction for: D00464 ( Oxazepam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.947145 1 1 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.943557 1 1 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.942975 1 1 1 0
4 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.940733 1 1 1 0
5 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.94072 1 1 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.85325 1 1 1 0
7 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.851405 1 1 1 0
8 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.849526 1 1 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.831157 1 1 1 0
10 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.829616 1 1 1 0

D00474 : Primidone (Found 9 out of 17 validated targets)

Top-10 predicted interaction for: D00474 ( Primidone )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.940017 1 0 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.935671 1 0 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.934987 1 0 1 0
4 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.93322 1 0 1 0
5 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.932913 1 0 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.826738 1 0 1 0
7 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.826368 1 0 1 0
8 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.825273 1 0 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.798744 1 0 1 0
10 hsa2741 ( glycine receptor alpha 1 ) 0.796338 0 0 0 0

D00477 : Procainamide hydrochloride (Found 2 out of 10 validated targets)

Top-10 predicted interaction for: D00477 ( Procainamide hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.973576 1 0 0 1
2 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.950547 0 0 0 0
3 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.813704 0 0 0 0
4 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.756403 1 0 0 1
5 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.710896 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.68825 0 0 0 0
7 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.671587 0 0 0 0
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.663373 0 0 0 0
9 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.659036 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.657788 0 0 0 0

D00480 : Promethazine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00480 ( Promethazine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.97374 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.94131 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.870739 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.851743 0 0 0 0
5 hsa6530 ( solute carrier family 6 member 2 ) 0.808228 0 0 0 0
6 hsa6532 ( solute carrier family 6 member 4 ) 0.789529 0 0 0 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.784655 0 0 0 0
8 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.727134 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.719725 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.706185 0 0 0 0

D00495 : Paramethadione (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00495 ( Paramethadione )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.984123 0 0 0 0
2 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.975034 0 0 0 0
3 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.815508 0 0 0 0
4 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.812264 0 0 0 0
5 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.786811 0 0 0 0
6 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.785186 0 0 0 0
7 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.783052 0 0 0 0
8 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.767555 0 0 0 0
9 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.766756 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.74067 0 0 0 0

D00499 : Pentobarbital (Found 2 out of 10 validated targets)

Top-10 predicted interaction for: D00499 ( Pentobarbital )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.887386 0 0 0 0
2 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.876167 0 0 0 0
3 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.875124 1 0 1 0
4 hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) 0.7997 0 0 0 0
5 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.797982 0 0 0 0
6 hsa2741 ( glycine receptor alpha 1 ) 0.785683 0 0 0 0
7 hsa2743 ( glycine receptor beta ) 0.718292 0 0 0 0
8 hsa2742 ( glycine receptor alpha 2 ) 0.712527 0 0 0 0
9 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.662887 1 0 1 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.640672 0 0 0 0

D00504 : Phenacemide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00504 ( Phenacemide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.986129 0 0 0 0
2 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.971803 0 0 0 0
3 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.969702 0 0 0 0
4 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.965211 0 0 0 0
5 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.962377 0 0 0 0
6 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.95857 0 0 0 0
7 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.957941 0 0 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.923972 0 0 0 0
9 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.808738 0 0 0 0
10 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.774086 0 0 0 0

D00512 : Phenytoin (Found 4 out of 4 validated targets)

Top-10 predicted interaction for: D00512 ( Phenytoin )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.747702 1 1 1 0
2 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.605337 0 0 0 0
3 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.58995 1 1 0 0
4 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.585449 1 1 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.551607 0 0 0 0
6 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.544533 1 1 0 0
7 hsa6530 ( solute carrier family 6 member 2 ) 0.510659 0 0 0 0
8 hsa40 ( acid sensing ion channel subunit 2 ) 0.503611 0 0 0 0
9 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.492144 0 0 0 0
10 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.478764 0 0 0 0

D00513 : Pindolol (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00513 ( Pindolol )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa170572 ( 5-hydroxytryptamine receptor 3C ) 0.936922 0 0 0 0
2 hsa200909 ( 5-hydroxytryptamine receptor 3D ) 0.934421 0 0 0 0
3 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.773644 0 0 0 0
4 hsa6530 ( solute carrier family 6 member 2 ) 0.763731 0 0 0 0
5 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.763112 0 0 0 0
6 hsa6532 ( solute carrier family 6 member 4 ) 0.745911 0 0 0 0
7 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.72888 0 0 0 0
8 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.67146 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.661337 0 0 0 0
10 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.657625 0 0 0 0

D00519 : Chlorothiazide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00519 ( Chlorothiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.845812 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.759255 0 0 0 0
3 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.7562 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.752036 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.692616 0 0 0 0
6 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.686098 0 0 0 0
7 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.685364 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.679923 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.668187 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.647903 0 0 0 0

D00521 : Terfenadine (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00521 ( Terfenadine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) 0.814779 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.765342 0 0 0 0
3 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.744315 0 0 0 0
4 hsa3776 ( potassium two pore domain channel subfamily K member 2 ) 0.730139 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.729988 0 0 0 0
6 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.728412 0 0 0 0
7 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.728006 0 0 0 0
8 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.719839 0 0 0 0
9 hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) 0.715181 0 0 0 0
10 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.712077 0 0 0 0

D00524 : Carbachol (Found 0 out of 27 validated targets)

Top-10 predicted interaction for: D00524 ( Carbachol )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.964678 0 0 0 0
2 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.96399 0 0 0 0
3 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.960313 0 0 0 0
4 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.878088 0 0 0 0
5 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.81521 0 0 0 0
6 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.769318 0 0 0 0
7 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.747931 0 0 0 0
8 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.732136 0 0 0 0
9 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.717318 0 0 0 0
10 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.711011 0 0 0 0

D00528 : Caffeine (Found 1 out of 36 validated targets)

Top-10 predicted interaction for: D00528 ( Caffeine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.955604 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.921328 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.776884 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.769335 0 0 0 0
5 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.749916 1 0 0 1
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.71517 0 0 0 0
7 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.687791 0 0 0 0
8 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.684463 0 0 0 0
9 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.683399 0 0 0 0
10 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.678848 0 0 0 0

D00530 : Zaleplon (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00530 ( Zaleplon )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2741 ( glycine receptor alpha 1 ) 0.846536 0 0 0 0
2 hsa2743 ( glycine receptor beta ) 0.804398 0 0 0 0
3 hsa2742 ( glycine receptor alpha 2 ) 0.782759 0 0 0 0
4 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.703945 0 0 0 0
5 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.69364 0 0 0 0
6 hsa6530 ( solute carrier family 6 member 2 ) 0.674694 0 0 0 0
7 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.674088 0 0 0 0
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.632815 0 0 0 0
9 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.627175 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.626174 0 0 0 0

D00533 : Oxcarbazepine (Found 6 out of 6 validated targets)

Top-10 predicted interaction for: D00533 ( Oxcarbazepine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.956998 0 0 0 0
2 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.953485 1 1 0 0
3 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.95238 1 1 0 0
4 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.947299 1 1 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.928957 1 1 0 0
6 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.927283 1 1 0 0
7 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.917014 1 1 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.889078 0 0 0 0
9 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.75189 0 0 0 0
10 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.723377 0 0 0 0

D00536 : Felbamate (Found 5 out of 31 validated targets)

Top-10 predicted interaction for: D00536 ( Felbamate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.891551 1 0 0 1
2 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.861639 1 0 0 1
3 hsa8001 ( glycine receptor alpha 3 ) 0.818774 0 0 0 0
4 hsa6532 ( solute carrier family 6 member 4 ) 0.774009 0 0 0 0
5 hsa6530 ( solute carrier family 6 member 2 ) 0.773376 0 0 0 0
6 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.731288 0 0 0 0
7 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.729882 1 0 0 1
8 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.722229 0 0 0 0
9 hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) 0.71627 1 0 0 1
10 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.716244 1 0 0 1

D00537 : Topiramate (Found 9 out of 31 validated targets)

Top-10 predicted interaction for: D00537 ( Topiramate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.939079 1 1 0 0
2 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.891145 1 1 0 0
3 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.89083 1 1 0 0
4 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.885906 1 1 0 0
5 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.878236 1 1 0 0
6 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.866461 1 1 0 0
7 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.853005 1 0 1 0
8 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.846249 0 0 0 0
9 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.843764 1 0 1 0
10 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.840097 1 0 1 0

D00538 : Zonisamide (Found 4 out of 5 validated targets)

Top-10 predicted interaction for: D00538 ( Zonisamide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.95078 1 1 1 0
2 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.828942 1 1 1 0
3 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.820741 1 1 0 0
4 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.797569 1 1 1 0
5 hsa40 ( acid sensing ion channel subunit 2 ) 0.713138 0 0 0 0
6 hsa5310 ( polycystin 1, transient receptor potential channel interacting ) 0.684373 0 0 0 0
7 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.683716 0 0 0 0
8 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.660511 0 0 0 0
9 hsa41 ( acid sensing ion channel subunit 1 ) 0.655843 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.638774 0 0 0 0

D00539 : Ethosuximide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00539 ( Ethosuximide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.801063 0 0 0 0
2 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.793441 0 0 0 0
3 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.789903 0 0 0 0
4 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.766788 0 0 0 0
5 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.762196 0 0 0 0
6 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.760654 0 0 0 0
7 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.740855 0 0 0 0
8 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.737727 0 0 0 0
9 hsa5310 ( polycystin 1, transient receptor potential channel interacting ) 0.731102 0 0 0 0
10 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.713135 0 0 0 0

D00542 : Halothane (Found 4 out of 23 validated targets)

Top-10 predicted interaction for: D00542 ( Halothane )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6261 ( ryanodine receptor 1 ) 0.853666 1 0 0 1
2 hsa6263 ( ryanodine receptor 3 ) 0.843711 1 0 0 1
3 hsa6262 ( ryanodine receptor 2 ) 0.790377 1 0 0 1
4 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.764386 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.664503 0 0 0 0
6 hsa2742 ( glycine receptor alpha 2 ) 0.586133 0 0 0 0
7 hsa6530 ( solute carrier family 6 member 2 ) 0.573278 0 0 0 0
8 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.552702 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.54704 0 0 0 0
10 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.535648 1 0 1 1

D00543 : Enflurane (Found 9 out of 16 validated targets)

Top-10 predicted interaction for: D00543 ( Enflurane )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2742 ( glycine receptor alpha 2 ) 0.878594 0 0 0 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.865319 1 0 1 1
3 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.864571 1 0 1 1
4 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.860136 1 0 1 1
5 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.854844 1 0 1 1
6 hsa2743 ( glycine receptor beta ) 0.850679 1 0 1 0
7 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.845622 1 0 1 1
8 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.788497 1 0 1 1
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.788448 1 0 1 1
10 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.773603 1 0 1 1

D00544 : Methoxyflurane (Found 7 out of 13 validated targets)

Top-10 predicted interaction for: D00544 ( Methoxyflurane )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2742 ( glycine receptor alpha 2 ) 0.872497 0 0 0 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.848292 1 0 1 0
3 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.847344 1 0 1 0
4 hsa2743 ( glycine receptor beta ) 0.842586 0 0 0 0
5 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.842388 1 0 1 0
6 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.836372 1 0 1 0
7 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.826375 1 0 1 0
8 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.773608 1 0 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.773576 1 0 1 0
10 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.768177 0 0 0 0

D00545 : Isoflurane (Found 2 out of 5 validated targets)

Top-10 predicted interaction for: D00545 ( Isoflurane )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2742 ( glycine receptor alpha 2 ) 0.887687 1 0 0 1
2 hsa2743 ( glycine receptor beta ) 0.88615 1 0 0 1
3 hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) 0.848577 0 0 0 0
4 hsa8001 ( glycine receptor alpha 3 ) 0.678807 0 0 0 0
5 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.668767 0 0 0 0
6 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.639852 0 0 0 0
7 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.62359 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.620397 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.598765 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.590089 0 0 0 0

D00546 : Desflurane (Found 8 out of 13 validated targets)

Top-10 predicted interaction for: D00546 ( Desflurane )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2742 ( glycine receptor alpha 2 ) 0.87753 0 0 0 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.875704 1 0 1 0
3 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.874922 1 0 1 0
4 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.871216 1 0 1 0
5 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.86611 1 0 1 0
6 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.857678 1 0 1 0
7 hsa2743 ( glycine receptor beta ) 0.853699 0 0 0 0
8 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.812772 1 0 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.811985 1 0 1 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.798629 1 0 1 0

D00547 : Sevoflurane (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00547 ( Sevoflurane )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) 0.869443 0 0 0 0
2 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.750641 0 0 0 0
3 hsa8001 ( glycine receptor alpha 3 ) 0.740735 0 0 0 0
4 hsa6530 ( solute carrier family 6 member 2 ) 0.666059 0 0 0 0
5 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.606516 0 0 0 0
6 hsa2897 ( glutamate ionotropic receptor kainate type subunit 1 ) 0.583207 0 0 0 0
7 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.582989 0 0 0 0
8 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.568328 0 0 0 0
9 hsa6532 ( solute carrier family 6 member 4 ) 0.561178 0 0 0 0
10 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.560243 0 0 0 0

D00548 : Etomidate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00548 ( Etomidate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) 0.86201 0 0 0 0
2 hsa2741 ( glycine receptor alpha 1 ) 0.843492 0 0 0 0
3 hsa2743 ( glycine receptor beta ) 0.802124 0 0 0 0
4 hsa2742 ( glycine receptor alpha 2 ) 0.782986 0 0 0 0
5 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.69187 0 0 0 0
6 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.671782 0 0 0 0
7 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.671371 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.648332 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.64802 0 0 0 0
10 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.647648 0 0 0 0

D00549 : Propofol (Found 0 out of 10 validated targets)

Top-10 predicted interaction for: D00549 ( Propofol )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.767268 0 0 0 0
2 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.75952 0 0 0 0
3 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.749984 0 0 0 0
4 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.745543 0 0 0 0
5 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.710345 0 0 0 0
6 hsa6530 ( solute carrier family 6 member 2 ) 0.706299 0 0 0 0
7 hsa8001 ( glycine receptor alpha 3 ) 0.693269 0 0 0 0
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.673208 0 0 0 0
9 hsa6532 ( solute carrier family 6 member 4 ) 0.620426 0 0 0 0
10 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.608739 0 0 0 0

D00550 : Midazolam (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00550 ( Midazolam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) 0.890114 1 0 1 0
2 hsa2741 ( glycine receptor alpha 1 ) 0.872689 0 0 0 0
3 hsa2743 ( glycine receptor beta ) 0.829992 0 0 0 0
4 hsa2742 ( glycine receptor alpha 2 ) 0.811343 0 0 0 0
5 hsa6530 ( solute carrier family 6 member 2 ) 0.735544 0 0 0 0
6 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.713285 0 0 0 0
7 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.696578 0 0 0 0
8 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.681328 0 0 0 0
9 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.678355 0 0 0 0
10 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.677832 0 0 0 0

D00552 : Benzocaine (Found 5 out of 5 validated targets)

Top-10 predicted interaction for: D00552 ( Benzocaine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.9645 1 1 0 0
2 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.917409 1 1 0 0
3 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.864065 1 1 0 0
4 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.860247 1 1 0 0
5 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.838561 1 1 0 0
6 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.828177 0 0 0 0
7 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.770018 0 0 0 0
8 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.744226 0 0 0 0
9 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.741453 0 0 0 0
10 hsa40 ( acid sensing ion channel subunit 2 ) 0.676932 0 0 0 0

D00553 : Prilocaine (Found 5 out of 6 validated targets)

Top-10 predicted interaction for: D00553 ( Prilocaine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.976596 1 1 0 0
2 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.972393 1 1 0 0
3 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.971735 1 1 0 0
4 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.96983 0 0 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.961552 1 1 0 0
6 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.959913 0 0 0 0
7 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.953796 0 0 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.928952 0 0 0 0
9 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.7503 1 1 0 0
10 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.74542 0 0 0 0

D00560 : Pimozide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00560 ( Pimozide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.823786 1 0 1 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.721176 0 0 0 0
3 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.611682 0 0 0 0
4 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.562723 0 0 0 0
5 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.553401 0 0 0 0
6 hsa56659 ( potassium two pore domain channel subfamily K member 13 ) 0.540849 0 0 0 0
7 hsa6530 ( solute carrier family 6 member 2 ) 0.53971 0 0 0 0
8 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.520876 0 0 0 0
9 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.513396 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.513281 0 0 0 0

D00563 : Mirtazapine (Found 6 out of 7 validated targets)

Top-10 predicted interaction for: D00563 ( Mirtazapine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.963786 1 1 0 0
2 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.955764 1 1 0 0
3 hsa170572 ( 5-hydroxytryptamine receptor 3C ) 0.905305 1 1 0 0
4 hsa200909 ( 5-hydroxytryptamine receptor 3D ) 0.900624 1 1 0 0
5 hsa6530 ( solute carrier family 6 member 2 ) 0.824518 1 0 1 0
6 hsa6532 ( solute carrier family 6 member 4 ) 0.810904 1 0 1 0
7 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.798283 0 0 0 0
8 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.743091 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.696825 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.694978 0 0 0 0

D00574 : Aminoglutethimide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00574 ( Aminoglutethimide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.941173 0 0 0 0
2 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.893672 0 0 0 0
3 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.8737 0 0 0 0
4 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.848087 0 0 0 0
5 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.846103 0 0 0 0
6 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.841056 0 0 0 0
7 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.809888 0 0 0 0
8 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.80331 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.789439 0 0 0 0
10 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.788762 0 0 0 0

D00593 : Glimepiride (Found 2 out of 2 validated targets)

Top-10 predicted interaction for: D00593 ( Glimepiride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.948154 1 0 1 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.915822 1 1 1 0
3 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.779849 0 0 0 0
4 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.750197 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.736279 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.729443 0 0 0 0
7 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.679748 0 0 0 0
8 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.673584 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.673051 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.663718 0 0 0 0

D00594 : Repaglinide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D00594 ( Repaglinide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.92645 0 0 0 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.883678 1 1 1 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.816168 0 0 0 0
4 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.771734 0 0 0 0
5 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.750972 0 0 0 0
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.73785 0 0 0 0
7 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.719494 0 0 0 0
8 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.71626 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.682454 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.665537 0 0 0 0

D00607 : Guanadrel sulfate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00607 ( Guanadrel sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.965793 0 0 0 0
2 hsa6531 ( solute carrier family 6 member 3 ) 0.957051 0 0 0 0
3 hsa11254 ( solute carrier family 6 member 14 ) 0.84161 0 0 0 0
4 hsa6534 ( solute carrier family 6 member 7 ) 0.817621 0 0 0 0
5 hsa6529 ( solute carrier family 6 member 1 ) 0.797115 0 0 0 0
6 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.748788 0 0 0 0
7 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.742894 0 0 0 0
8 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.73025 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.700722 0 0 0 0
10 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.699118 0 0 0 0

D00611 : Mecamylamine hydrochloride (Found 4 out of 4 validated targets)

Top-10 predicted interaction for: D00611 ( Mecamylamine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.969627 1 1 0 1
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.879936 1 1 0 1
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.862807 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.795789 0 0 0 0
5 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.771892 1 1 0 0
6 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.714263 0 0 0 0
7 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.712232 0 0 0 0
8 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.704974 1 1 0 0
9 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.696377 0 0 0 0
10 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.688184 0 0 0 0

D00615 : Amlodipine besylate (Found 4 out of 5 validated targets)

Top-10 predicted interaction for: D00615 ( Amlodipine besylate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.94111 1 0 0 1
2 hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) 0.92772 0 0 0 0
3 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.924116 0 0 0 0
4 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.921714 1 0 1 1
5 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.904916 1 0 1 0
6 hsa774 ( calcium voltage-gated channel subunit alpha1 B ) 0.874697 1 0 1 0
7 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.873312 0 0 0 0
8 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.865928 0 0 0 0
9 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.855905 0 0 0 0
10 hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) 0.854774 0 0 0 0

D00616 : Diltiazem hydrochloride (Found 1 out of 2 validated targets)

Top-10 predicted interaction for: D00616 ( Diltiazem hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.938098 0 0 0 0
2 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.909023 1 1 0 0
3 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.902748 0 0 0 0
4 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.902101 0 0 0 0
5 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.869009 0 0 0 0
6 hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) 0.836308 0 0 0 0
7 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.809855 0 0 0 0
8 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.798466 0 0 0 0
9 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.771478 0 0 0 0
10 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.733536 0 0 0 0

D00617 : Nicardipine hydrochloride (Found 2 out of 2 validated targets)

Top-10 predicted interaction for: D00617 ( Nicardipine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.916038 0 0 0 0
2 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.910829 0 0 0 0
3 hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) 0.901247 0 0 0 0
4 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.89464 1 0 1 0
5 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.893225 0 0 0 0
6 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.872893 1 0 1 0
7 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.852872 0 0 0 0
8 hsa774 ( calcium voltage-gated channel subunit alpha1 B ) 0.84336 0 0 0 0
9 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.837343 0 0 0 0
10 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.835671 0 0 0 0

D00618 : Nisoldipine (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00618 ( Nisoldipine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.694272 0 0 0 0
2 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.655559 0 0 0 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.647692 0 0 0 0
4 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.579472 0 0 0 0
5 hsa56659 ( potassium two pore domain channel subfamily K member 13 ) 0.559771 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.553701 0 0 0 0
7 hsa6340 ( sodium channel epithelial 1 gamma subunit ) 0.546757 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.53538 0 0 0 0
9 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.533067 0 0 0 0
10 hsa6324 ( sodium voltage-gated channel beta subunit 1 ) 0.519301 0 0 0 0

D00619 : Verapamil hydrochloride (Found 10 out of 122 validated targets)

Top-10 predicted interaction for: D00619 ( Verapamil hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.950995 1 1 1 1
2 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.929047 1 0 0 1
3 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.917527 1 0 0 1
4 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.902834 1 0 1 1
5 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.896146 1 1 1 1
6 hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) 0.892087 1 0 0 1
7 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.885799 1 0 0 1
8 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.882314 1 0 0 1
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.85526 1 0 0 1
10 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.851592 1 0 1 1

D00629 : Nitrendipine (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00629 ( Nitrendipine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.701304 0 0 0 0
2 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.676411 0 0 0 0
3 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.650964 0 0 0 0
4 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.61177 0 0 0 0
5 hsa56659 ( potassium two pore domain channel subfamily K member 13 ) 0.562142 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.55467 0 0 0 0
7 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.543686 0 0 0 0
8 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.542654 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.540834 0 0 0 0
10 hsa6340 ( sodium channel epithelial 1 gamma subunit ) 0.518005 0 0 0 0

D00631 : Bepridil hydrochloride (Found 2 out of 49 validated targets)

Top-10 predicted interaction for: D00631 ( Bepridil hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.87222 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.858448 0 0 0 0
3 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.855338 1 1 1 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.834299 0 0 0 0
5 hsa6530 ( solute carrier family 6 member 2 ) 0.808199 0 0 0 0
6 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.805932 0 0 0 0
7 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.772409 1 1 0 0
8 hsa6532 ( solute carrier family 6 member 4 ) 0.771533 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.764415 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.752413 0 0 0 0

D00633 : Dopamine hydrochloride (Found 0 out of 3 validated targets)

Top-10 predicted interaction for: D00633 ( Dopamine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.802381 0 0 0 0
2 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.726925 0 0 0 0
3 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.697565 0 0 0 0
4 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.695836 0 0 0 0
5 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.686825 0 0 0 0
6 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.686778 0 0 0 0
7 hsa6261 ( ryanodine receptor 1 ) 0.683828 0 0 0 0
8 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.676776 0 0 0 0
9 hsa2741 ( glycine receptor alpha 1 ) 0.673835 0 0 0 0
10 hsa8001 ( glycine receptor alpha 3 ) 0.664989 0 0 0 0

D00636 : Amiodarone hydrochloride (Found 0 out of 10 validated targets)

Top-10 predicted interaction for: D00636 ( Amiodarone hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.940225 0 0 0 0
2 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.920528 0 0 0 0
3 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.891493 0 0 0 0
4 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.884539 0 0 0 0
5 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.86173 0 0 0 0
6 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.8549 0 0 0 0
7 hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) 0.833729 0 0 0 0
8 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.82249 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.821237 0 0 0 0
10 hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) 0.806464 0 0 0 0

D00638 : Flecainide acetate (Found 1 out of 4 validated targets)

Top-10 predicted interaction for: D00638 ( Flecainide acetate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.951505 0 0 0 0
2 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.92935 0 0 0 0
3 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.88519 0 0 0 0
4 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.808794 0 0 0 0
5 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.799033 0 0 0 0
6 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.747488 0 0 0 0
7 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.710233 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.704492 0 0 0 0
9 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.703214 0 0 0 0
10 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.700993 1 1 0 0

D00639 : Mexiletine hydrochloride (Found 2 out of 10 validated targets)

Top-10 predicted interaction for: D00639 ( Mexiletine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.978837 1 0 0 1
2 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.952055 0 0 0 0
3 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.81315 0 0 0 0
4 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.793518 1 0 0 1
5 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.750014 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.717781 0 0 0 0
7 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.69626 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.659314 0 0 0 0
9 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.651215 0 0 0 0
10 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.612249 0 0 0 0

D00640 : Propafenone hydrochloride (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00640 ( Propafenone hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.957755 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.810058 0 0 0 0
3 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.786655 0 0 0 0
4 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.714586 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.712433 0 0 0 0
6 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.687058 0 0 0 0
7 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.679643 0 0 0 0
8 hsa9424 ( potassium two pore domain channel subfamily K member 6 ) 0.673947 0 0 0 0
9 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.671973 0 0 0 0
10 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.671326 0 0 0 0

D00642 : Quinidine gluconate (Found 1 out of 2 validated targets)

Top-10 predicted interaction for: D00642 ( Quinidine gluconate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.907586 0 0 0 0
2 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.899129 0 0 0 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.889687 1 0 1 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.807111 0 0 0 0
5 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.794827 0 0 0 0
6 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.790506 0 0 0 0
7 hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) 0.744829 0 0 0 0
8 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.736237 0 0 0 0
9 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.731125 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.717802 0 0 0 0

D00647 : Dofetilide (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00647 ( Dofetilide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa9424 ( potassium two pore domain channel subfamily K member 6 ) 0.862996 0 0 0 0
2 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.862872 0 0 0 0
3 hsa3756 ( potassium voltage-gated channel subfamily H member 1 ) 0.859274 0 0 0 0
4 hsa83795 ( potassium two pore domain channel subfamily K member 16 ) 0.80294 0 0 0 0
5 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.797808 0 0 0 0
6 hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) 0.746961 0 0 0 0
7 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.743062 0 0 0 0
8 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.731479 0 0 0 0
9 hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) 0.725576 0 0 0 0
10 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.722758 0 0 0 0

D00648 : Ibutilide fumarate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00648 ( Ibutilide fumarate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) 0.882406 0 0 0 0
2 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.861544 0 0 0 0
3 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.844301 0 0 0 0
4 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.840006 0 0 0 0
5 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.837741 0 0 0 0
6 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.818083 0 0 0 0
7 hsa3756 ( potassium voltage-gated channel subfamily H member 1 ) 0.771487 0 0 0 0
8 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.757339 0 0 0 0
9 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.756396 0 0 0 0
10 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.753698 0 0 0 0

D00649 : Amiloride hydrochloride (Found 6 out of 31 validated targets)

Top-10 predicted interaction for: D00649 ( Amiloride hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6330 ( sodium voltage-gated channel beta subunit 4 ) 0.930276 1 0 0 1
2 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.929398 1 0 0 1
3 hsa55800 ( sodium voltage-gated channel beta subunit 3 ) 0.899396 1 0 0 1
4 hsa6324 ( sodium voltage-gated channel beta subunit 1 ) 0.845717 1 0 0 1
5 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.834395 1 0 0 1
6 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.751104 1 0 0 1
7 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.750113 0 0 0 0
8 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.742095 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.703903 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.690101 0 0 0 0

D00650 : Bendroflumethiazide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00650 ( Bendroflumethiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.845259 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.761797 0 0 0 0
3 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.761578 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.760287 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.706386 0 0 0 0
6 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.692748 0 0 0 0
7 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.686765 0 0 0 0
8 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.677925 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.672041 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.653517 0 0 0 0

D00651 : Benzthiazide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00651 ( Benzthiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.843834 0 0 0 0
2 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.807249 0 0 0 0
3 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.755992 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.744324 0 0 0 0
5 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.693932 0 0 0 0
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.679911 0 0 0 0
7 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.679556 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.672786 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.670145 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.654907 0 0 0 0

D00654 : Hydroflumethiazide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00654 ( Hydroflumethiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.84915 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.760948 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.756197 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.746746 0 0 0 0
5 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.690577 0 0 0 0
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.686886 0 0 0 0
7 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.686665 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.674881 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.664413 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.643153 0 0 0 0

D00656 : Methyclothiazide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00656 ( Methyclothiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.863935 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.759263 0 0 0 0
3 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.757327 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.748443 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.702924 0 0 0 0
6 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.697838 0 0 0 0
7 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.694195 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.680313 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.66176 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.642297 0 0 0 0

D00658 : Trichlormethiazide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00658 ( Trichlormethiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.859855 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.760016 0 0 0 0
3 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.758479 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.742657 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.700154 0 0 0 0
6 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.693037 0 0 0 0
7 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.689712 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.681732 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.664112 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.643127 0 0 0 0

D00677 : Granisetron hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00677 ( Granisetron hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.766479 0 0 0 0
2 hsa2741 ( glycine receptor alpha 1 ) 0.725745 0 0 0 0
3 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.724831 0 0 0 0
4 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.714335 0 0 0 0
5 hsa8001 ( glycine receptor alpha 3 ) 0.711826 0 0 0 0
6 hsa2742 ( glycine receptor alpha 2 ) 0.703551 0 0 0 0
7 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.698444 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.69231 0 0 0 0
9 hsa6261 ( ryanodine receptor 1 ) 0.678368 0 0 0 0
10 hsa6532 ( solute carrier family 6 member 4 ) 0.671329 0 0 0 0

D00678 : Ondansetron hydrochloride hydrate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00678 ( Ondansetron hydrochloride hydrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.7809 0 0 0 0
2 hsa6530 ( solute carrier family 6 member 2 ) 0.742269 0 0 0 0
3 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.74172 0 0 0 0
4 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.733133 0 0 0 0
5 hsa6532 ( solute carrier family 6 member 4 ) 0.72381 0 0 0 0
6 hsa6261 ( ryanodine receptor 1 ) 0.700444 0 0 0 0
7 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.693932 0 0 0 0
8 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.683659 0 0 0 0
9 hsa8001 ( glycine receptor alpha 3 ) 0.679126 0 0 0 0
10 hsa2741 ( glycine receptor alpha 1 ) 0.6788 0 0 0 0

D00694 : Clorazepate dipotassium (Found 10 out of 13 validated targets)

Top-10 predicted interaction for: D00694 ( Clorazepate dipotassium )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.956629 1 1 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.953429 1 1 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.953156 1 1 1 0
4 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.951327 1 1 1 0
5 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.951048 1 1 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.876394 1 1 1 0
7 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.873995 1 1 1 0
8 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.873689 1 1 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.858162 1 1 1 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.856419 1 1 1 0

D00697 : Flumazenil (Found 10 out of 13 validated targets)

Top-10 predicted interaction for: D00697 ( Flumazenil )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.948773 1 1 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.945075 1 1 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.945029 1 1 1 0
4 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.942991 1 1 1 0
5 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.942567 1 1 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.858136 1 1 1 0
7 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.85677 1 1 1 0
8 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.854583 1 1 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.839268 1 1 1 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.837985 1 1 1 0

D00704 : Ethchlorvynol (Found 9 out of 13 validated targets)

Top-10 predicted interaction for: D00704 ( Ethchlorvynol )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.944619 1 0 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.941135 1 0 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.940424 1 0 1 0
4 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.938525 1 0 1 0
5 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.937808 1 0 1 0
6 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.838919 1 0 1 0
7 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.836938 1 0 1 0
8 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.836588 1 0 1 0
9 hsa2741 ( glycine receptor alpha 1 ) 0.834024 0 0 0 0
10 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.814066 1 0 1 0

D00708 : Ethotoin (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00708 ( Ethotoin )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.961813 0 0 0 0
2 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.955887 0 0 0 0
3 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.95348 0 0 0 0
4 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.949405 0 0 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.936231 0 0 0 0
6 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.932979 0 0 0 0
7 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.923457 0 0 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.88546 0 0 0 0
9 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.727956 0 0 0 0
10 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.71035 0 0 0 0

D00709 : Levetiracetam (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00709 ( Levetiracetam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.973636 0 0 0 0
2 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.954678 0 0 0 0
3 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.954436 0 0 0 0
4 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.94641 0 0 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.940374 0 0 0 0
6 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.937299 0 0 0 0
7 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.932226 0 0 0 0
8 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.932147 0 0 0 0
9 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.926393 0 0 0 0
10 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.852543 0 0 0 0

D00711 : Ketamine hydrochloride (Found 9 out of 18 validated targets)

Top-10 predicted interaction for: D00711 ( Ketamine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.848193 1 0 0 1
2 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.843368 1 0 0 1
3 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.838687 1 0 0 1
4 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.797821 1 0 0 1
5 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.78541 1 0 0 1
6 hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) 0.777286 1 0 0 1
7 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.773667 1 0 0 1
8 hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) 0.764346 1 0 0 1
9 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.760914 1 0 0 1
10 hsa2741 ( glycine receptor alpha 1 ) 0.758519 0 0 0 0

D00726 : Metoclopramide (Found 2 out of 2 validated targets)

Top-10 predicted interaction for: D00726 ( Metoclopramide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.955479 0 0 0 0
2 hsa170572 ( 5-hydroxytryptamine receptor 3C ) 0.790065 1 1 0 0
3 hsa200909 ( 5-hydroxytryptamine receptor 3D ) 0.784197 1 1 0 0
4 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.775571 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.69478 0 0 0 0
6 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.688024 0 0 0 0
7 hsa6530 ( solute carrier family 6 member 2 ) 0.683219 0 0 0 0
8 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.672123 0 0 0 0
9 hsa6532 ( solute carrier family 6 member 4 ) 0.669418 0 0 0 0
10 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.629975 0 0 0 0

D00732 : Chloroprocaine hydrochloride (Found 1 out of 4 validated targets)

Top-10 predicted interaction for: D00732 ( Chloroprocaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.786675 0 0 0 0
2 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.774245 0 0 0 0
3 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.718483 0 0 0 0
4 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.705355 0 0 0 0
5 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.674164 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.658572 1 0 1 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.648816 0 0 0 0
8 hsa6261 ( ryanodine receptor 1 ) 0.635026 0 0 0 0
9 hsa6263 ( ryanodine receptor 3 ) 0.603661 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.60005 0 0 0 0

D00733 : Dibucaine (Found 6 out of 6 validated targets)

Top-10 predicted interaction for: D00733 ( Dibucaine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.958448 1 1 0 0
2 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.957783 1 1 0 0
3 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.954119 1 1 0 0
4 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.931988 1 1 0 0
5 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.929403 1 1 0 0
6 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.916311 1 1 0 0
7 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.881059 0 0 0 0
8 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.798135 0 0 0 0
9 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.749136 0 0 0 0
10 hsa6324 ( sodium voltage-gated channel beta subunit 1 ) 0.736682 0 0 0 0

D00735 : Dyclonine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00735 ( Dyclonine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.793749 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.778477 0 0 0 0
3 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.735858 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.705718 0 0 0 0
5 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.702767 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.656499 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.61861 0 0 0 0
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.613417 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.602637 0 0 0 0
10 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.597125 0 0 0 0

D00738 : Mepivacaine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00738 ( Mepivacaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.827025 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.788697 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.746124 0 0 0 0
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.71464 0 0 0 0
5 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.699678 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.67499 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.649859 0 0 0 0
8 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.623409 0 0 0 0
9 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.598822 0 0 0 0
10 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.591468 0 0 0 0

D00739 : Pramoxine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00739 ( Pramoxine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.807393 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.775277 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.719747 0 0 0 0
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.719469 0 0 0 0
5 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.694139 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.664573 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.634865 0 0 0 0
8 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.610832 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.604227 0 0 0 0
10 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.595692 0 0 0 0

D00740 : Procaine hydrochloride (Found 4 out of 45 validated targets)

Top-10 predicted interaction for: D00740 ( Procaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.783337 1 0 0 1
2 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.763651 1 0 0 1
3 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.721423 0 0 0 0
4 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.693489 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.657757 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.639533 0 0 0 0
7 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.625766 0 0 0 0
8 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.619775 1 0 0 1
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.618011 1 0 1 1
10 hsa6530 ( solute carrier family 6 member 2 ) 0.574459 0 0 0 0

D00741 : Tetracaine hydrochloride (Found 1 out of 3 validated targets)

Top-10 predicted interaction for: D00741 ( Tetracaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.804028 0 0 0 0
2 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.781855 0 0 0 0
3 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.737496 0 0 0 0
4 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.718388 0 0 0 0
5 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.687548 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.664202 0 0 0 0
7 hsa6261 ( ryanodine receptor 1 ) 0.612449 1 0 0 1
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.612075 0 0 0 0
9 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.598873 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.593462 0 0 0 0

D00759 : Cisatracurium besylate (Found 1 out of 4 validated targets)

Top-10 predicted interaction for: D00759 ( Cisatracurium besylate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.959511 0 0 0 0
2 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.950053 0 0 0 0
3 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.948675 0 0 0 0
4 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.943746 0 0 0 0
5 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.942496 0 0 0 0
6 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.939167 0 0 0 0
7 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.935586 0 0 0 0
8 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.933353 0 0 0 0
9 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.924952 1 1 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.834391 0 0 0 0

D00760 : Doxacurium chloride (Found 1 out of 4 validated targets)

Top-10 predicted interaction for: D00760 ( Doxacurium chloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.957548 0 0 0 0
2 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.947639 0 0 0 0
3 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.945814 0 0 0 0
4 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.941801 0 0 0 0
5 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.940765 0 0 0 0
6 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.936358 0 0 0 0
7 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.932015 0 0 0 0
8 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.929745 0 0 0 0
9 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.920809 1 1 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.831677 0 0 0 0

D00761 : Metocurine iodide (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00761 ( Metocurine iodide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.959814 0 0 0 0
2 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.950538 0 0 0 0
3 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.949049 0 0 0 0
4 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.945095 0 0 0 0
5 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.944211 0 0 0 0
6 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.939807 0 0 0 0
7 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.935604 0 0 0 0
8 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.933747 0 0 0 0
9 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.925246 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.815609 0 0 0 0

D00765 : Rocuronium bromide (Found 2 out of 5 validated targets)

Top-10 predicted interaction for: D00765 ( Rocuronium bromide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.960688 0 0 0 0
2 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.953745 0 0 0 0
3 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.95119 0 0 0 0
4 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.948982 0 0 0 0
5 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.944933 0 0 0 0
6 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.940245 0 0 0 0
7 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.934451 0 0 0 0
8 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.93274 0 0 0 0
9 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.925158 1 1 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.828001 1 0 1 0

D00771 : Chlorzoxazone (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00771 ( Chlorzoxazone )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.84406 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.781412 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.775804 0 0 0 0
4 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.701814 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.699529 0 0 0 0
6 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.695975 0 0 0 0
7 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.695157 0 0 0 0
8 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.675275 0 0 0 0
9 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.674295 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.672562 0 0 0 0

D00775 : Riluzole (Found 2 out of 27 validated targets)

Top-10 predicted interaction for: D00775 ( Riluzole )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.842849 0 0 0 0
2 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.809645 0 0 0 0
3 hsa2898 ( glutamate ionotropic receptor kainate type subunit 2 ) 0.772445 1 0 0 1
4 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.760157 0 0 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.758562 0 0 0 0
6 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.724128 0 0 0 0
7 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.685926 1 0 0 1
8 hsa40 ( acid sensing ion channel subunit 2 ) 0.683321 0 0 0 0
9 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.666691 0 0 0 0
10 hsa41 ( acid sensing ion channel subunit 1 ) 0.652452 0 0 0 0

D00779 : Biperiden (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00779 ( Biperiden )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.954187 0 0 0 0
2 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.944625 0 0 0 0
3 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.943493 0 0 0 0
4 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.941248 0 0 0 0
5 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.936846 0 0 0 0
6 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.93116 0 0 0 0
7 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.924698 0 0 0 0
8 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.92315 0 0 0 0
9 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.914489 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.835207 0 0 0 0

D00791 : Fluphenazine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00791 ( Fluphenazine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.978653 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.951277 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.90634 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.859905 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.793705 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.74299 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.735665 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.720767 0 0 0 0
9 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.70923 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.683927 0 0 0 0

D00798 : Thioridazine hydrochloride (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00798 ( Thioridazine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.920305 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.908394 0 0 0 0
3 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.860879 0 0 0 0
4 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.829509 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.822208 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.808895 0 0 0 0
7 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.762257 0 0 0 0
8 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.740728 0 0 0 0
9 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.737041 0 0 0 0
10 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.719126 0 0 0 0

D00799 : Trifluoperazine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00799 ( Trifluoperazine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.982761 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.958268 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.916579 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.86601 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.792444 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.755998 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.74945 0 0 0 0
8 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.714902 0 0 0 0
9 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.712619 0 0 0 0
10 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.701736 0 0 0 0

D00809 : Amitriptyline hydrochloride (Found 2 out of 7 validated targets)

Top-10 predicted interaction for: D00809 ( Amitriptyline hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.949185 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.875663 0 0 0 0
3 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.858999 0 0 0 0
4 hsa6530 ( solute carrier family 6 member 2 ) 0.792404 1 1 1 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.777573 0 0 0 0
6 hsa6532 ( solute carrier family 6 member 4 ) 0.766722 1 1 1 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.740892 0 0 0 0
8 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.721068 0 0 0 0
9 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.71017 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.704018 0 0 0 0

D00812 : Desipramine hydrochloride (Found 2 out of 2 validated targets)

Top-10 predicted interaction for: D00812 ( Desipramine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.973907 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.940062 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.867325 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.857094 0 0 0 0
5 hsa6530 ( solute carrier family 6 member 2 ) 0.839121 1 1 1 1
6 hsa6532 ( solute carrier family 6 member 4 ) 0.814438 1 1 1 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.788884 0 0 0 0
8 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.723139 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.721658 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.702205 0 0 0 0

D00816 : Nortriptyline hydrochloride (Found 2 out of 2 validated targets)

Top-10 predicted interaction for: D00816 ( Nortriptyline hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.974583 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.939233 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.868372 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.853209 0 0 0 0
5 hsa6530 ( solute carrier family 6 member 2 ) 0.841677 1 1 1 1
6 hsa6532 ( solute carrier family 6 member 4 ) 0.817073 1 1 1 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.787672 0 0 0 0
8 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.732791 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.721517 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.707314 0 0 0 0

D00823 : Fluoxetine hydrochloride (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D00823 ( Fluoxetine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.846993 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.78618 0 0 0 0
3 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.767154 0 0 0 0
4 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.736924 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.711774 0 0 0 0
6 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.709619 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.708133 0 0 0 0
8 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.686628 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.659752 0 0 0 0
10 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.657681 0 0 0 0

D00831 : Mefloquine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00831 ( Mefloquine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3753 ( potassium voltage-gated channel subfamily E regulatory subunit 1 ) 0.894264 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.825492 0 0 0 0
3 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.809134 0 0 0 0
4 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.788985 0 0 0 0
5 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.784658 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.759675 0 0 0 0
7 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.749187 0 0 0 0
8 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.731028 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.714004 0 0 0 0
10 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.709912 0 0 0 0

D00960 : Anastrozole (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00960 ( Anastrozole )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.94035 0 0 0 0
2 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.892658 0 0 0 0
3 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.872452 0 0 0 0
4 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.843504 0 0 0 0
5 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.842252 0 0 0 0
6 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.83536 0 0 0 0
7 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.806675 0 0 0 0
8 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.804744 0 0 0 0
9 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.78077 0 0 0 0
10 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.779672 0 0 0 0

D00963 : Exemestane (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00963 ( Exemestane )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.954587 0 0 0 0
2 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.915522 0 0 0 0
3 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.897479 0 0 0 0
4 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.874833 0 0 0 0
5 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.87229 0 0 0 0
6 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.870093 0 0 0 0
7 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.841568 0 0 0 0
8 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.827425 0 0 0 0
9 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.822859 0 0 0 0
10 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.821528 0 0 0 0

D00964 : Letrozole (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D00964 ( Letrozole )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.943693 0 0 0 0
2 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.901119 0 0 0 0
3 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.880726 0 0 0 0
4 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.854615 0 0 0 0
5 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.853048 0 0 0 0
6 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.848794 0 0 0 0
7 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.818847 0 0 0 0
8 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.809524 0 0 0 0
9 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.799175 0 0 0 0
10 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.798414 0 0 0 0

D01071 : Hexobarbital (Found 10 out of 17 validated targets)

Top-10 predicted interaction for: D01071 ( Hexobarbital )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.945705 1 1 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.941448 1 1 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.941305 1 1 1 0
4 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.938785 1 1 1 0
5 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.938623 1 1 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.839957 1 1 0 0
7 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.839201 1 1 0 0
8 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.839112 1 1 0 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.814228 1 1 0 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.809143 1 1 0 0

D01108 : Magnesium sulfate (Found 3 out of 3 validated targets)

Top-10 predicted interaction for: D01108 ( Magnesium sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.957015 1 0 1 0
2 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.956484 0 0 0 0
3 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.953831 0 0 0 0
4 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.931318 1 0 1 0
5 hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) 0.926095 0 0 0 0
6 hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) 0.924671 1 0 1 0
7 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.912074 0 0 0 0
8 hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) 0.863027 0 0 0 0
9 hsa9254 ( calcium voltage-gated channel auxiliary subunit alpha2delta 2 ) 0.851596 0 0 0 0
10 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.845025 0 0 0 0

D01111 : Nateglinide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D01111 ( Nateglinide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.934868 0 0 0 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.901478 1 1 1 0
3 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.765247 0 0 0 0
4 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.743976 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.738995 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.736527 0 0 0 0
7 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.710689 0 0 0 0
8 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.690783 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.674241 0 0 0 0
10 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.655584 0 0 0 0

D01118 : Profenamine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01118 ( Profenamine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.862673 0 0 0 0
2 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.833872 0 0 0 0
3 hsa6530 ( solute carrier family 6 member 2 ) 0.824069 0 0 0 0
4 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.806181 0 0 0 0
5 hsa116444 ( glutamate ionotropic receptor NMDA type subunit 3B ) 0.772817 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.727325 0 0 0 0
7 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.724894 0 0 0 0
8 hsa2904 ( glutamate ionotropic receptor NMDA type subunit 2B ) 0.718873 0 0 0 0
9 hsa2902 ( glutamate ionotropic receptor NMDA type subunit 1 ) 0.717833 0 0 0 0
10 hsa2906 ( glutamate ionotropic receptor NMDA type subunit 2D ) 0.7154 0 0 0 0

D01242 : Promethazine teoclate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01242 ( Promethazine teoclate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.973511 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.941491 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.874147 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.852634 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.785877 0 0 0 0
6 hsa6530 ( solute carrier family 6 member 2 ) 0.78422 0 0 0 0
7 hsa6532 ( solute carrier family 6 member 4 ) 0.76139 0 0 0 0
8 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.727294 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.718583 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.699648 0 0 0 0

D01243 : Prilocaine hydrochloride (Found 1 out of 2 validated targets)

Top-10 predicted interaction for: D01243 ( Prilocaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.806308 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.793478 1 1 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.722403 0 0 0 0
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.7201 0 0 0 0
5 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.712138 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.656668 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.634912 0 0 0 0
8 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.608527 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.602038 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.589429 0 0 0 0

D01253 : Clobazam (Found 10 out of 13 validated targets)

Top-10 predicted interaction for: D01253 ( Clobazam )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.960533 1 1 1 0
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.957518 1 1 1 0
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.9574 1 1 1 0
4 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.955772 1 1 1 0
5 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.955417 1 1 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.890938 1 1 1 0
7 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.887659 1 1 1 0
8 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.887461 1 1 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.875184 1 1 1 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.874317 1 1 1 0

D01256 : Cyclothiazide (Found 5 out of 33 validated targets)

Top-10 predicted interaction for: D01256 ( Cyclothiazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.855 1 0 0 1
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.753835 0 0 0 0
3 hsa2893 ( glutamate ionotropic receptor AMPA type subunit 4 ) 0.750694 1 0 0 1
4 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.750639 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.749077 1 0 0 1
6 hsa2892 ( glutamate ionotropic receptor AMPA type subunit 3 ) 0.745722 1 0 0 1
7 hsa2897 ( glutamate ionotropic receptor kainate type subunit 1 ) 0.723153 1 0 0 1
8 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.699386 0 0 0 0
9 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.698206 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.67522 0 0 0 0

D01275 : Doxorubicin hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01275 ( Doxorubicin hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.876178 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.860084 0 0 0 0
3 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.744454 0 0 0 0
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.735823 0 0 0 0
5 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.731117 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.694957 0 0 0 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.684993 0 0 0 0
8 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.663882 0 0 0 0
9 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.662928 0 0 0 0
10 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.662481 0 0 0 0

D01287 : Levobupivacaine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01287 ( Levobupivacaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.833434 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.782593 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.742168 0 0 0 0
4 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.699075 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.685949 0 0 0 0
6 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.680661 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.650156 0 0 0 0
8 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.628585 0 0 0 0
9 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.60863 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.598817 0 0 0 0

D01295 : Cinnarizine (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01295 ( Cinnarizine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.777855 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.706341 0 0 0 0
3 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.599619 0 0 0 0
4 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.551191 0 0 0 0
5 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.540442 0 0 0 0
6 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.533945 0 0 0 0
7 hsa56659 ( potassium two pore domain channel subfamily K member 13 ) 0.531939 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.529872 0 0 0 0
9 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.504922 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.494948 0 0 0 0

D01350 : Streptomycin sulfate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01350 ( Streptomycin sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.899529 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.87403 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.711154 0 0 0 0
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.699723 0 0 0 0
5 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.69907 0 0 0 0
6 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.688411 0 0 0 0
7 hsa5026 ( purinergic receptor P2X 5 ) 0.6855 0 0 0 0
8 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.685284 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.68273 0 0 0 0
10 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.652523 0 0 0 0

D01448 : Trifluoperazine maleate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01448 ( Trifluoperazine maleate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.983056 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.95455 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.897478 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.866864 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.772547 0 0 0 0
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.756528 0 0 0 0
7 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.735162 0 0 0 0
8 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.716196 0 0 0 0
9 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.70892 0 0 0 0
10 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.705391 0 0 0 0

D01450 : Bupivacaine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01450 ( Bupivacaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.767412 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.720418 0 0 0 0
3 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.715948 0 0 0 0
4 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.649784 0 0 0 0
5 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.646798 0 0 0 0
6 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.64301 0 0 0 0
7 hsa83795 ( potassium two pore domain channel subfamily K member 16 ) 0.630563 0 0 0 0
8 hsa9424 ( potassium two pore domain channel subfamily K member 6 ) 0.624529 0 0 0 0
9 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.624405 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.623561 0 0 0 0

D01453 : Caffeine hydrate (Found 5 out of 43 validated targets)

Top-10 predicted interaction for: D01453 ( Caffeine hydrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.782775 0 0 0 0
2 hsa5026 ( purinergic receptor P2X 5 ) 0.780182 1 0 0 1
3 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.773265 0 0 0 0
4 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.769888 0 0 0 0
5 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.757015 0 0 0 0
6 hsa5024 ( purinergic receptor P2X 3 ) 0.731373 1 0 0 1
7 hsa5027 ( purinergic receptor P2X 7 ) 0.725032 1 0 0 1
8 hsa5025 ( purinergic receptor P2X 4 ) 0.722815 1 0 0 1
9 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.720695 0 0 0 0
10 hsa9127 ( purinergic receptor P2X 6 ) 0.718232 1 0 0 1

D01575 : Dequalinium chloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01575 ( Dequalinium chloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.980274 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.978644 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.898903 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.88228 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.781868 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.742346 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.741578 0 0 0 0
8 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.72279 0 0 0 0
9 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.699997 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.671344 0 0 0 0

D01599 : Gliclazide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D01599 ( Gliclazide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.966725 0 0 0 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.861409 1 1 1 1
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.761716 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.748058 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.706161 0 0 0 0
6 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.687614 0 0 0 0
7 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.682071 0 0 0 0
8 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.669898 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.66377 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.65649 0 0 0 0

D01603 : Bethanidine sulfate (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D01603 ( Bethanidine sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.963767 0 0 0 0
2 hsa6531 ( solute carrier family 6 member 3 ) 0.950157 0 0 0 0
3 hsa11254 ( solute carrier family 6 member 14 ) 0.837355 0 0 0 0
4 hsa6534 ( solute carrier family 6 member 7 ) 0.815399 0 0 0 0
5 hsa6529 ( solute carrier family 6 member 1 ) 0.790653 0 0 0 0
6 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.721485 0 0 0 0
7 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.708761 0 0 0 0
8 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.702945 0 0 0 0
9 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.687125 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.68669 1 0 1 0

D01712 : Theophylline sodium acetate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01712 ( Theophylline sodium acetate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.81049 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.791007 0 0 0 0
3 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.790655 0 0 0 0
4 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.764411 0 0 0 0
5 hsa5026 ( purinergic receptor P2X 5 ) 0.763999 0 0 0 0
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.721566 0 0 0 0
7 hsa5024 ( purinergic receptor P2X 3 ) 0.713421 0 0 0 0
8 hsa5027 ( purinergic receptor P2X 7 ) 0.709172 0 0 0 0
9 hsa5025 ( purinergic receptor P2X 4 ) 0.706957 0 0 0 0
10 hsa9127 ( purinergic receptor P2X 6 ) 0.700773 0 0 0 0

D01768 : Benoxinate hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01768 ( Benoxinate hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.989475 0 0 0 0
2 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.972947 0 0 0 0
3 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.972755 0 0 0 0
4 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.96982 0 0 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.956403 0 0 0 0
6 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.954471 0 0 0 0
7 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.94541 0 0 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.915608 0 0 0 0
9 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.819262 0 0 0 0
10 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.755298 0 0 0 0

D01799 : Glyclopyramide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D01799 ( Glyclopyramide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.968931 0 0 0 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.86585 1 1 0 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.769687 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.749699 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.702786 0 0 0 0
6 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.686515 0 0 0 0
7 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.68442 0 0 0 0
8 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.666781 0 0 0 0
9 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.655624 0 0 0 0
10 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.648475 0 0 0 0

D01828 : Amlexanox (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D01828 ( Amlexanox )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.942238 0 0 0 0
2 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.895954 0 0 0 0
3 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.842069 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.772094 0 0 0 0
5 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.747203 0 0 0 0
6 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.690611 0 0 0 0
7 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.683928 0 0 0 0
8 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.677819 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.669366 0 0 0 0
10 hsa6261 ( ryanodine receptor 1 ) 0.66215 0 0 0 0

D01854 : Mitiglinide calcium hydrate (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D01854 ( Mitiglinide calcium hydrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.95012 0 0 0 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.802316 1 1 1 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.789619 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.784346 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.752028 0 0 0 0
6 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.72375 0 0 0 0
7 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.692174 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.691132 0 0 0 0
9 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.667667 0 0 0 0
10 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.660042 0 0 0 0

D01969 : Gallopamil hydrochloride (Found 7 out of 25 validated targets)

Top-10 predicted interaction for: D01969 ( Gallopamil hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.980737 1 1 0 1
2 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.96897 1 1 0 1
3 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.961056 1 0 0 1
4 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.900811 1 0 0 1
5 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.881568 1 0 0 1
6 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.873132 0 0 0 0
7 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.871483 1 0 0 1
8 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.857075 1 0 0 1
9 hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) 0.855118 0 0 0 0
10 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.848788 0 0 0 0

D02041 : Tropisetron hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02041 ( Tropisetron hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2743 ( glycine receptor beta ) 0.830159 0 0 0 0
2 hsa6530 ( solute carrier family 6 member 2 ) 0.808539 0 0 0 0
3 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.796537 0 0 0 0
4 hsa6532 ( solute carrier family 6 member 4 ) 0.762482 0 0 0 0
5 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.750934 0 0 0 0
6 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.729667 0 0 0 0
7 hsa6531 ( solute carrier family 6 member 3 ) 0.71108 0 0 0 0
8 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.686064 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.682252 0 0 0 0
10 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.680243 0 0 0 0

D02086 : Lidocaine hydrochloride (Found 1 out of 9 validated targets)

Top-10 predicted interaction for: D02086 ( Lidocaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.804087 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.796199 1 0 0 1
3 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.733318 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.713143 0 0 0 0
5 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.710913 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.656645 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.629203 0 0 0 0
8 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.605101 0 0 0 0
9 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.597854 0 0 0 0
10 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.597375 0 0 0 0

D02087 : Moricizine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02087 ( Moricizine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.962502 0 0 0 0
2 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.934381 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.841845 0 0 0 0
4 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.801278 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.723752 0 0 0 0
6 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.720255 0 0 0 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.712393 0 0 0 0
8 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.701924 0 0 0 0
9 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.681543 0 0 0 0
10 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.662814 0 0 0 0

D02088 : Tocainide hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02088 ( Tocainide hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.976725 0 0 0 0
2 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.952255 0 0 0 0
3 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.819595 0 0 0 0
4 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.77906 0 0 0 0
5 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.737144 0 0 0 0
6 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.734838 0 0 0 0
7 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.69082 0 0 0 0
8 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.66784 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.658988 0 0 0 0
10 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.610291 0 0 0 0

D02092 : Cisapride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02092 ( Cisapride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) 0.821594 0 0 0 0
2 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.783067 0 0 0 0
3 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.764562 0 0 0 0
4 hsa3776 ( potassium two pore domain channel subfamily K member 2 ) 0.751978 0 0 0 0
5 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.746167 0 0 0 0
6 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.716619 0 0 0 0
7 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.712277 0 0 0 0
8 hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) 0.70633 0 0 0 0
9 hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) 0.702034 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.701642 0 0 0 0

D02098 : Proparacaine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02098 ( Proparacaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.940591 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.79964 0 0 0 0
3 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.760404 0 0 0 0
4 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.749662 0 0 0 0
5 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.716523 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.6548 0 0 0 0
7 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.653768 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.649043 0 0 0 0
9 hsa6261 ( ryanodine receptor 1 ) 0.624095 0 0 0 0
10 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.622894 0 0 0 0

D02101 : Codeine phosphate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02101 ( Codeine phosphate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.973667 0 0 0 0
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.896246 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.861632 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.795272 0 0 0 0
5 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.78884 0 0 0 0
6 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.776207 0 0 0 0
7 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.723109 0 0 0 0
8 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.720567 0 0 0 0
9 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.683434 0 0 0 0
10 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.669454 0 0 0 0

D02163 : Fluphenazine maleate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02163 ( Fluphenazine maleate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.979872 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.954155 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.905376 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.861858 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.781542 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.729873 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.727423 0 0 0 0
8 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.711847 0 0 0 0
9 hsa6530 ( solute carrier family 6 member 2 ) 0.71123 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.700337 0 0 0 0

D02173 : Galantamine hydrobromide (Found 4 out of 4 validated targets)

Top-10 predicted interaction for: D02173 ( Galantamine hydrobromide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.967225 1 0 1 0
2 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.902692 0 0 0 0
3 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.887257 1 0 1 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.793064 0 0 0 0
5 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.783157 1 0 1 0
6 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.761592 0 0 0 0
7 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.75922 0 0 0 0
8 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.717255 1 0 1 0
9 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.701887 0 0 0 0
10 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.68649 0 0 0 0

D02204 : Hexamethonium bromide (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D02204 ( Hexamethonium bromide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.964985 1 1 0 0
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.86814 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.826631 0 0 0 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.764839 0 0 0 0
5 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.748947 0 0 0 0
6 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.739323 0 0 0 0
7 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.731913 0 0 0 0
8 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.683893 0 0 0 0
9 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.664328 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.646818 0 0 0 0

D02207 : Tubocurarine chloride (Found 3 out of 4 validated targets)

Top-10 predicted interaction for: D02207 ( Tubocurarine chloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.933062 0 0 0 0
2 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.861009 0 0 0 0
3 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.799004 1 1 0 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.759068 0 0 0 0
5 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.755539 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.749879 1 0 1 0
7 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.74847 0 0 0 0
8 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.730978 0 0 0 0
9 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.673781 0 0 0 0
10 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.671301 1 1 0 0

D02234 : Cyproheptadine hydrochloride (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D02234 ( Cyproheptadine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.978851 0 0 0 0
2 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.943485 0 0 0 0
3 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.863447 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.851549 0 0 0 0
5 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.795508 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.775744 0 0 0 0
7 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.74614 0 0 0 0
8 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.732934 0 0 0 0
9 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.711512 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.708689 1 0 0 1

D02237 : Guanethidine sulfate (Found 2 out of 8 validated targets)

Top-10 predicted interaction for: D02237 ( Guanethidine sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.966065 0 0 0 0
2 hsa6531 ( solute carrier family 6 member 3 ) 0.956277 0 0 0 0
3 hsa11254 ( solute carrier family 6 member 14 ) 0.839532 0 0 0 0
4 hsa6534 ( solute carrier family 6 member 7 ) 0.816616 0 0 0 0
5 hsa6529 ( solute carrier family 6 member 1 ) 0.796066 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.724076 0 0 0 0
7 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.720203 0 0 0 0
8 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.715486 1 0 0 1
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.711712 0 0 0 0
10 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.709177 1 0 0 1

D02253 : Pentobarbital calcium (Found 9 out of 27 validated targets)

Top-10 predicted interaction for: D02253 ( Pentobarbital calcium )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.912837 1 1 1 1
2 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.912577 1 1 1 1
3 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.910957 1 1 1 1
4 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.880356 1 1 1 1
5 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.877095 1 1 1 1
6 hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) 0.875712 1 0 0 1
7 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.875237 1 1 1 1
8 hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) 0.871086 1 1 1 1
9 hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) 0.862823 1 1 1 1
10 hsa2741 ( glycine receptor alpha 1 ) 0.813644 0 0 0 0

D02261 : Quinine hydrochloride hydrate (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D02261 ( Quinine hydrochloride hydrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.939029 0 0 0 0
2 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.913462 0 0 0 0
3 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.858608 0 0 0 0
4 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.852635 0 0 0 0
5 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.835225 0 0 0 0
6 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.826376 0 0 0 0
7 hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) 0.825745 0 0 0 0
8 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.799971 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.79029 0 0 0 0
10 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.763733 0 0 0 0

D02262 : Quinine sulfate (Found 0 out of 1 validated targets)

Top-10 predicted interaction for: D02262 ( Quinine sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.930478 0 0 0 0
2 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.899897 0 0 0 0
3 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.855096 0 0 0 0
4 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.848163 0 0 0 0
5 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.823375 0 0 0 0
6 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.815469 0 0 0 0
7 hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) 0.812527 0 0 0 0
8 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.790274 0 0 0 0
9 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.761406 0 0 0 0
10 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.759552 0 0 0 0

D02272 : Quinidine sulfate (Found 1 out of 2 validated targets)

Top-10 predicted interaction for: D02272 ( Quinidine sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.898009 0 0 0 0
2 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.895848 0 0 0 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.88947 1 0 1 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.828815 0 0 0 0
5 hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) 0.787992 0 0 0 0
6 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.783109 0 0 0 0
7 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.747179 0 0 0 0
8 hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) 0.739358 0 0 0 0
9 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.732783 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.69611 0 0 0 0

D02347 : Dantrolene (Found 2 out of 2 validated targets)

Top-10 predicted interaction for: D02347 ( Dantrolene )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6263 ( ryanodine receptor 3 ) 0.970142 1 1 0 0
2 hsa6262 ( ryanodine receptor 2 ) 0.966156 1 1 0 0
3 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.84462 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.823606 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.802144 0 0 0 0
6 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.699873 0 0 0 0
7 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.697864 0 0 0 0
8 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.680453 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.666607 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.664413 0 0 0 0

D02356 : Verapamil (Found 1 out of 14 validated targets)

Top-10 predicted interaction for: D02356 ( Verapamil )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.75149 1 0 1 0
2 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.539372 0 0 0 0
3 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.432318 0 0 0 0
4 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.403761 0 0 0 0
5 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.376561 0 0 0 0
6 hsa3776 ( potassium two pore domain channel subfamily K member 2 ) 0.363173 0 0 0 0
7 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.359564 0 0 0 0
8 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.353044 0 0 0 0
9 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.332447 0 0 0 0
10 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.324746 0 0 0 0

D02360 : Sertraline (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D02360 ( Sertraline )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6530 ( solute carrier family 6 member 2 ) 0.976258 0 0 0 0
2 hsa6531 ( solute carrier family 6 member 3 ) 0.93186 1 0 1 0
3 hsa11254 ( solute carrier family 6 member 14 ) 0.840278 0 0 0 0
4 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.820671 0 0 0 0
5 hsa6534 ( solute carrier family 6 member 7 ) 0.816478 0 0 0 0
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.801074 0 0 0 0
7 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.793629 0 0 0 0
8 hsa6529 ( solute carrier family 6 member 1 ) 0.787438 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.731077 0 0 0 0
10 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.723385 0 0 0 0

D02362 : Paroxetine (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D02362 ( Paroxetine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6530 ( solute carrier family 6 member 2 ) 0.975019 1 0 1 0
2 hsa6531 ( solute carrier family 6 member 3 ) 0.933407 0 0 0 0
3 hsa11254 ( solute carrier family 6 member 14 ) 0.841437 0 0 0 0
4 hsa6534 ( solute carrier family 6 member 7 ) 0.816929 0 0 0 0
5 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.811746 0 0 0 0
6 hsa6529 ( solute carrier family 6 member 1 ) 0.794954 0 0 0 0
7 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.74071 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.73808 0 0 0 0
9 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.737271 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.724032 0 0 0 0

D02409 : Caffeine and sodium benzoate (Found 4 out of 43 validated targets)

Top-10 predicted interaction for: D02409 ( Caffeine and sodium benzoate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.800948 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.7775 0 0 0 0
3 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.765553 0 0 0 0
4 hsa6833 ( ATP binding cassette subfamily C member 8 ) 0.761103 0 0 0 0
5 hsa5026 ( purinergic receptor P2X 5 ) 0.75045 1 0 0 1
6 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.720051 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.711 0 0 0 0
8 hsa5024 ( purinergic receptor P2X 3 ) 0.699703 1 0 0 1
9 hsa5025 ( purinergic receptor P2X 4 ) 0.694343 1 0 0 1
10 hsa5027 ( purinergic receptor P2X 7 ) 0.694293 1 0 0 1

D02461 : Penicillin G procaine (Found 0 out of 41 validated targets)

Top-10 predicted interaction for: D02461 ( Penicillin G procaine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.875665 0 0 0 0
2 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.874401 0 0 0 0
3 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.873988 0 0 0 0
4 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.830158 0 0 0 0
5 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.825192 0 0 0 0
6 hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) 0.824099 0 0 0 0
7 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.822649 0 0 0 0
8 hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) 0.815959 0 0 0 0
9 hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) 0.806097 0 0 0 0
10 hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) 0.781326 0 0 0 0

D02485 : Halofantrine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02485 ( Halofantrine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.822651 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.817902 0 0 0 0
3 hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) 0.81497 0 0 0 0
4 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.798274 0 0 0 0
5 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.764879 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.760597 0 0 0 0
7 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.741214 0 0 0 0
8 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.721844 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.719366 0 0 0 0
10 hsa3776 ( potassium two pore domain channel subfamily K member 2 ) 0.717417 0 0 0 0

D02546 : Kainic acid hydrate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02546 ( Kainic acid hydrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) 0.891716 0 0 0 0
2 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.886708 0 0 0 0
3 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.797313 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.794021 0 0 0 0
5 hsa2892 ( glutamate ionotropic receptor AMPA type subunit 3 ) 0.792478 0 0 0 0
6 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.777848 0 0 0 0
7 hsa2893 ( glutamate ionotropic receptor AMPA type subunit 4 ) 0.760024 0 0 0 0
8 hsa2895 ( glutamate ionotropic receptor delta type subunit 2 ) 0.752219 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.741266 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.740116 0 0 0 0

D02566 : Maprotiline (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02566 ( Maprotiline )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.97204 0 0 0 0
2 hsa6531 ( solute carrier family 6 member 3 ) 0.948695 0 0 0 0
3 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.873826 0 0 0 0
4 hsa11254 ( solute carrier family 6 member 14 ) 0.843816 0 0 0 0
5 hsa6534 ( solute carrier family 6 member 7 ) 0.822314 0 0 0 0
6 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.800316 0 0 0 0
7 hsa6529 ( solute carrier family 6 member 1 ) 0.793504 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.722784 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.720986 0 0 0 0
10 hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) 0.713335 0 0 0 0

D02630 : Penfluridol (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D02630 ( Penfluridol )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.861231 0 0 0 0
2 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.848778 0 0 0 0
3 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.828596 0 0 0 0
4 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.828593 0 0 0 0
5 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.828249 0 0 0 0
6 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.825135 0 0 0 0
7 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.814836 0 0 0 0
8 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.811302 0 0 0 0
9 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.798379 0 0 0 0
10 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.791662 0 0 0 0

D02914 : Amlodipine maleate (Found 5 out of 5 validated targets)

Top-10 predicted interaction for: D02914 ( Amlodipine maleate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.939844 1 0 0 1
2 hsa777 ( calcium voltage-gated channel subunit alpha1 E ) 0.931716 0 0 0 0
3 hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) 0.931626 0 0 0 0
4 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.926616 1 0 1 1
5 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.903972 1 0 1 0
6 hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) 0.901485 0 0 0 0
7 hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) 0.894562 0 0 0 0
8 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.88934 0 0 0 0
9 hsa774 ( calcium voltage-gated channel subunit alpha1 B ) 0.884253 1 0 1 0
10 hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) 0.865196 1 0 1 0

D03037 : Azimilide dihydrochloride (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D03037 ( Azimilide dihydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3753 ( potassium voltage-gated channel subfamily E regulatory subunit 1 ) 0.890028 0 0 0 0
2 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.788641 0 0 0 0
3 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.771313 0 0 0 0
4 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.764018 0 0 0 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.751877 0 0 0 0
6 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.751169 0 0 0 0
7 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.742552 1 1 0 0
8 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.72869 0 0 0 0
9 hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) 0.699004 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.683636 0 0 0 0

D03180 : Butabarbital (Found 10 out of 17 validated targets)

Top-10 predicted interaction for: D03180 ( Butabarbital )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.949676 1 0 1 0
2 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.945553 1 0 1 0
3 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.945505 1 0 1 0
4 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.943273 1 0 1 0
5 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.943023 1 0 1 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.849248 1 0 1 0
7 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.848019 1 0 1 0
8 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.84781 1 0 1 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.823154 1 0 1 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.81872 1 0 1 0

D03274 : Chlorpromazine hibenzate (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D03274 ( Chlorpromazine hibenzate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.946937 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.878562 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.871285 0 0 0 0
4 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.795827 1 0 1 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.784552 0 0 0 0
6 hsa6530 ( solute carrier family 6 member 2 ) 0.748401 0 0 0 0
7 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.72507 0 0 0 0
8 hsa6532 ( solute carrier family 6 member 4 ) 0.709512 0 0 0 0
9 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.709336 0 0 0 0
10 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.705087 0 0 0 0

D03365 : Nicotine (Found 3 out of 3 validated targets)

Top-10 predicted interaction for: D03365 ( Nicotine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.965774 1 0 1 0
2 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.959932 1 0 1 0
3 hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) 0.959924 1 0 1 0
4 hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) 0.95599 0 0 0 0
5 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.834253 0 0 0 0
6 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.830583 0 0 0 0
7 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.824231 0 0 0 0
8 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.785364 0 0 0 0
9 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.756282 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.723605 0 0 0 0

D03450 : Cetiedil citrate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D03450 ( Cetiedil citrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.91924 0 0 0 0
2 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.9088 0 0 0 0
3 hsa1080 ( cystic fibrosis transmembrane conductance regulator ) 0.900792 0 0 0 0
4 hsa6261 ( ryanodine receptor 1 ) 0.885705 0 0 0 0
5 hsa6262 ( ryanodine receptor 2 ) 0.874858 0 0 0 0
6 hsa6263 ( ryanodine receptor 3 ) 0.874648 0 0 0 0
7 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.850581 0 0 0 0
8 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.807472 0 0 0 0
9 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.785195 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.743173 0 0 0 0

D03580 : Codeine sulfate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D03580 ( Codeine sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.965854 0 0 0 0
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.878152 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.836421 0 0 0 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.798229 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.794638 0 0 0 0
6 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.761244 0 0 0 0
7 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.7284 0 0 0 0
8 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.696509 0 0 0 0
9 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.663496 0 0 0 0
10 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.661896 0 0 0 0

D03742 : Dextromethorphan (Found 4 out of 10 validated targets)

Top-10 predicted interaction for: D03742 ( Dextromethorphan )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6530 ( solute carrier family 6 member 2 ) 0.920092 1 0 1 0
2 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.883195 1 0 1 0
3 hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) 0.877707 0 0 0 0
4 hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) 0.85246 1 0 1 0
5 hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) 0.842489 0 0 0 0
6 hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) 0.839067 0 0 0 0
7 hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) 0.829764 1 0 1 0
8 hsa6531 ( solute carrier family 6 member 3 ) 0.818666 0 0 0 0
9 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.817819 0 0 0 0
10 hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) 0.812881 0 0 0 0

D03826 : Physostigmine sulfate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D03826 ( Physostigmine sulfate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.95576 0 0 0 0
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.867027 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.831524 0 0 0 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.812422 0 0 0 0
5 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.795726 0 0 0 0
6 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.74706 0 0 0 0
7 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.731739 0 0 0 0
8 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.682467 0 0 0 0
9 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.674415 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.673544 0 0 0 0

D03830 : Diltiazem malate (Found 1 out of 2 validated targets)

Top-10 predicted interaction for: D03830 ( Diltiazem malate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.939403 0 0 0 0
2 hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) 0.905772 0 0 0 0
3 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.903247 1 1 0 0
4 hsa773 ( calcium voltage-gated channel subunit alpha1 A ) 0.894649 0 0 0 0
5 hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) 0.868293 0 0 0 0
6 hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) 0.839862 0 0 0 0
7 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.801023 0 0 0 0
8 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.797138 0 0 0 0
9 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.790667 0 0 0 0
10 hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) 0.712744 0 0 0 0

D03878 : Dizocilpine maleate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D03878 ( Dizocilpine maleate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.791873 0 0 0 0
2 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.788585 0 0 0 0
3 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.782504 0 0 0 0
4 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.77592 0 0 0 0
5 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.74582 0 0 0 0
6 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.733026 0 0 0 0
7 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.726698 0 0 0 0
8 hsa6532 ( solute carrier family 6 member 4 ) 0.706267 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.68819 0 0 0 0
10 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.679275 0 0 0 0

D03991 : Encainide hydrochloride (Found 2 out of 10 validated targets)

Top-10 predicted interaction for: D03991 ( Encainide hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.967333 1 0 0 1
2 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.939202 0 0 0 0
3 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.82242 0 0 0 0
4 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.817959 0 0 0 0
5 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.736718 1 0 0 1
6 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.715228 0 0 0 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.676301 0 0 0 0
8 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.674164 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.637679 0 0 0 0
10 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.633898 0 0 0 0

D04034 : Chlorpromazine phenolphthalinate (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D04034 ( Chlorpromazine phenolphthalinate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.943099 0 0 0 0
2 hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) 0.878738 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.866495 0 0 0 0
4 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.799578 1 0 1 0
5 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.774782 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.719115 0 0 0 0
7 hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) 0.704091 0 0 0 0
8 hsa6530 ( solute carrier family 6 member 2 ) 0.70321 0 0 0 0
9 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.702828 0 0 0 0
10 hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) 0.681519 0 0 0 0

D04048 : Ropivacaine hydrochloride (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D04048 ( Ropivacaine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.83716 0 0 0 0
2 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.785035 0 0 0 0
3 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.744544 0 0 0 0
4 hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) 0.707172 0 0 0 0
5 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.690174 0 0 0 0
6 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.676231 0 0 0 0
7 hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) 0.658867 0 0 0 0
8 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.625175 0 0 0 0
9 hsa54207 ( potassium two pore domain channel subfamily K member 10 ) 0.616226 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.595702 0 0 0 0

D04370 : Granisetron (Found 4 out of 4 validated targets)

Top-10 predicted interaction for: D04370 ( Granisetron )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa285242 ( 5-hydroxytryptamine receptor 3E ) 0.965323 1 1 0 0
2 hsa9177 ( 5-hydroxytryptamine receptor 3B ) 0.957084 1 1 0 0
3 hsa170572 ( 5-hydroxytryptamine receptor 3C ) 0.917119 1 1 0 0
4 hsa200909 ( 5-hydroxytryptamine receptor 3D ) 0.913835 1 1 0 0
5 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.79325 0 0 0 0
6 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.74293 0 0 0 0
7 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.728869 0 0 0 0
8 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.717164 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.71322 0 0 0 0
10 hsa6530 ( solute carrier family 6 member 2 ) 0.713121 0 0 0 0

D04790 : Lubiprostone (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D04790 ( Lubiprostone )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6530 ( solute carrier family 6 member 2 ) 0.824492 0 0 0 0
2 hsa6532 ( solute carrier family 6 member 4 ) 0.754065 0 0 0 0
3 hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) 0.749136 0 0 0 0
4 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.744668 0 0 0 0
5 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.741967 0 0 0 0
6 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.729284 0 0 0 0
7 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.719379 0 0 0 0
8 hsa6531 ( solute carrier family 6 member 3 ) 0.705042 0 0 0 0
9 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.701347 0 0 0 0
10 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.698783 0 0 0 0

D04985 : Methohexital (Found 10 out of 14 validated targets)

Top-10 predicted interaction for: D04985 ( Methohexital )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.950428 1 0 0 1
2 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.946423 1 0 0 1
3 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.946388 1 0 0 1
4 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.943944 1 0 0 1
5 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.943768 1 0 0 1
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.846415 1 0 0 1
7 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.846075 1 0 0 1
8 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.845683 1 0 0 1
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.819182 1 0 0 1
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.814265 1 0 0 1

D04999 : Methylphenidate (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D04999 ( Methylphenidate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.967676 1 0 1 0
2 hsa11254 ( solute carrier family 6 member 14 ) 0.856566 0 0 0 0
3 hsa6529 ( solute carrier family 6 member 1 ) 0.834828 0 0 0 0
4 hsa6534 ( solute carrier family 6 member 7 ) 0.832994 0 0 0 0
5 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.756164 0 0 0 0
6 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.745239 0 0 0 0
7 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.734074 0 0 0 0
8 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.715147 0 0 0 0
9 hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) 0.702249 0 0 0 0
10 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.698421 0 0 0 0

D05024 : Mibefradil dihydrochloride (Found 5 out of 5 validated targets)

Top-10 predicted interaction for: D05024 ( Mibefradil dihydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa775 ( calcium voltage-gated channel subunit alpha1 C ) 0.978078 1 0 0 1
2 hsa779 ( calcium voltage-gated channel subunit alpha1 S ) 0.975366 0 0 0 0
3 hsa778 ( calcium voltage-gated channel subunit alpha1 F ) 0.973281 1 0 0 1
4 hsa776 ( calcium voltage-gated channel subunit alpha1 D ) 0.963014 1 0 0 1
5 hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) 0.89641 1 0 0 1
6 hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) 0.888283 1 0 0 1
7 hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) 0.879274 0 0 0 0
8 hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) 0.872008 0 0 0 0
9 hsa774 ( calcium voltage-gated channel subunit alpha1 B ) 0.849906 0 0 0 0
10 hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) 0.834176 0 0 0 0

D05077 : Moricizine (Found 6 out of 6 validated targets)

Top-10 predicted interaction for: D05077 ( Moricizine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.959354 1 1 0 0
2 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.953147 1 1 0 0
3 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.952746 0 0 0 0
4 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.948798 1 1 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.935734 1 1 0 0
6 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.93443 1 1 0 0
7 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.925776 1 1 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.898714 0 0 0 0
9 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.837143 0 0 0 0
10 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.757647 0 0 0 0

D05156 : Nicotine bitartrate (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D05156 ( Nicotine bitartrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.960879 1 0 1 0
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.862174 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.806747 0 0 0 0
4 hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) 0.802623 0 0 0 0
5 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.76532 0 0 0 0
6 hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) 0.747027 0 0 0 0
7 hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) 0.735243 0 0 0 0
8 hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) 0.72164 0 0 0 0
9 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.719069 0 0 0 0
10 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.689571 0 0 0 0

D05453 : Phencyclidine hydrochloride (Found 0 out of 5 validated targets)

Top-10 predicted interaction for: D05453 ( Phencyclidine hydrochloride )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) 0.966131 0 0 0 0
2 hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) 0.877543 0 0 0 0
3 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.833529 0 0 0 0
4 hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) 0.784018 0 0 0 0
5 hsa1144 ( cholinergic receptor nicotinic delta subunit ) 0.75624 0 0 0 0
6 hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) 0.705178 0 0 0 0
7 hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) 0.69362 0 0 0 0
8 hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) 0.688659 0 0 0 0
9 hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) 0.663062 0 0 0 0
10 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.642581 0 0 0 0

D05458 : Phentermine (Found 1 out of 1 validated targets)

Top-10 predicted interaction for: D05458 ( Phentermine )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6532 ( solute carrier family 6 member 4 ) 0.968459 1 0 1 0
2 hsa11254 ( solute carrier family 6 member 14 ) 0.853287 0 0 0 0
3 hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) 0.837978 0 0 0 0
4 hsa6529 ( solute carrier family 6 member 1 ) 0.829425 0 0 0 0
5 hsa6534 ( solute carrier family 6 member 7 ) 0.828043 0 0 0 0
6 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.776309 0 0 0 0
7 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.728076 0 0 0 0
8 hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) 0.687278 0 0 0 0
9 hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) 0.682253 0 0 0 0
10 hsa3359 ( 5-hydroxytryptamine receptor 3A ) 0.678775 0 0 0 0

D05461 : Enoxacin hydrate (Found 0 out of 0 validated targets)

Top-10 predicted interaction for: D05461 ( Enoxacin hydrate )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.889263 0 0 0 0
2 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.889129 0 0 0 0
3 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.888595 0 0 0 0
4 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.846614 0 0 0 0
5 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.843287 0 0 0 0
6 hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) 0.841513 0 0 0 0
7 hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) 0.84054 0 0 0 0
8 hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) 0.839383 0 0 0 0
9 hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) 0.827727 0 0 0 0
10 hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) 0.786767 0 0 0 0

D06106 : Thiamylal (Found 10 out of 15 validated targets)

Top-10 predicted interaction for: D06106 ( Thiamylal )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) 0.952547 1 1 0 0
2 hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) 0.948647 1 1 0 0
3 hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) 0.94857 1 1 0 0
4 hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) 0.946448 1 1 0 0
5 hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) 0.946156 1 1 0 0
6 hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) 0.853138 1 1 0 0
7 hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) 0.852193 1 1 0 0
8 hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) 0.85171 1 1 0 0
9 hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) 0.825799 1 1 0 0
10 hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) 0.821269 1 1 0 0

D06172 : Tocainide (Found 6 out of 6 validated targets)

Top-10 predicted interaction for: D06172 ( Tocainide )
RankTargetScoreValidatedKEGGDrugBankMatador
1 hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) 0.976669 1 1 0 0
2 hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) 0.97252 1 1 0 0
3 hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) 0.971519 0 0 0 0
4 hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) 0.970004 1 1 0 0
5 hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) 0.961816 1 1 0 0
6 hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) 0.960249 1 1 0 0
7 hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) 0.954249 1 1 0 0
8 hsa8645 ( potassium two pore domain channel subfamily K member 5 ) 0.929685 0 0 0 0
9 hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) 0.747751 0 0 0 0
10 hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) 0.747021 0 0 0 0